Acute pancreatitis (for exclusion)

PANCREATITIS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K85 Hospital discharge: ICD-9 — 5770 Hospital discharge: ICD-8 — 5770 Cause of death: ICD-10 — K85 Cause of death: ICD-9 — 5770 Cause of death: ICD-8 — 5770 2 out of 7 registries used, show all original rules.	8694
4. Check minimum number of events None	8694
5. Include endpoints None	8694
6. Filter based on genotype QC (FinnGen only)	8694

Control definitions (FinnGen only)

Control exclude: IBD_CMV

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: K80-K87
Name in latin: Pancreatitis acuta

NAME	PANCREATITIS
CONTROL_EXCLUDE	IBD_CMV
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K85
HD_ICD_9	5770
HD_ICD_8	5770
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K85
COD_ICD_9	5770
COD_ICD_8	5770
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Acute pancreatitis (for exclusion) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8694	3476	5218
Unadjusted period prevalence (%)	1.85	1.18	2.30
Median age at first event (years)	54.39	53.43	55.02

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7809: Matched controls
78099

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

6.2

323.0

1649

3225

K85

ICD-10 Finland

Acute pancreatitis

1359.4

323.0

2567

57709

ICD-8 Finland

Diseases of pancreas, Pancreatitis NUD

+∞

323.0

441

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

4.4

323.0

1960

5502

K85.0

ICD-10 Finland

Idiopathic acute pancreatitis

4872.5

323.0

889

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

125.3

323.0

438

K85.8

ICD-10 Finland

Other acute pancreatitis

9292.8

323.0

842

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

7198.4

323.0

2877

JN3AD

NOMESCO Finland

Abdominal CT examination

6.4

323.0

1523

2834

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

3815.7

323.0

717

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

5.5

323.0

1838

4125

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

4.0

323.0

4040

16609

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

22.4

323.0

587

282

57708

ICD-8 Finland

Diseases of pancreas, Pancreatitis acuta alia

+∞

323.0

367

K86.3

ICD-10 Finland

Pseudocyst of pancreas

122.5

323.0

472

5770A

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA NONALCOHOLICA NONHAEMORRHAGICA]

+∞

323.0

363

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

6.5

323.0

1962

3847

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

15.9

323.0

545

366

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

87.0

323.0

1179

159

UJK02

NOMESCO Finland

ERCP

16.2

323.0

886

611

5770D

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICA NONHAEMORHAGICA]

+∞

323.0

445

R10.1

ICD-10 Finland

Pain localized to upper abdomen

4.8

323.0

2284

6229

K86.1

ICD-10 Finland

Other chronic pancreatitis

76.5

323.0

730

105

A09AA02

ATC

multienzymes (lipase, protease etc.)

17.9

323.0

741

455

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

16.2

323.0

765

521

JN3BD

NOMESCO Finland

Extensive abdominal CT

6.1

323.0

2005

4181

K85.1

ICD-10 Finland

Biliary acute pancreatitis

11025.3

323.0

978

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

9.4

298.2

649

747

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

15.2

280.3

480

336

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.5

270.0

1051

2591

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

14.4

269.1

471

347

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.5

266.5

2819

14336

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

21.3

265.9

401

198

N02AX02

ATC

tramadol; systemic, rectal

2.3

262.0

3934

23851

A02BC02

ATC

pantoprazole; systemic

2.2

221.1

5326

38689

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

5.8

212.1

647

1205

103

Kela drug reimbursment

Diabetes, insulin-treated

2.3

205.4

2654

14475

K86.9

ICD-10 Finland

Disease of pancreas, unspecified

43.9

201.0

251

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

200.9

2080

10143

K86.01

ICD-10 Finland

Late effects of pancreatitis caused by alcohol

194.2

200.1

208

JLW98

NOMESCO Finland

Other transluminal endoscopic operation on pancreas

116.3

198.2

215

K83.0

ICD-10 Finland

Cholangitis

11.9

198.0

377

332

A10AE04

ATC

insulin glargine; parenteral

3.1

183.4

1128

3994

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.5

180.4

933

2902

J01MA12

ATC

levofloxacin; systemic

2.4

180.1

1860

8975

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

178.4

3724

24485

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.2

171.0

2301

12554

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

7.0

168.1

436

651

JKE12

NOMESCO Finland

Endoscopic extraction of calculus from bile duct

12.4

167.4

312

262

K83.1

ICD-10 Finland

Obstruction of bile duct

11.4

165.0

320

292

R10.0

ICD-10 Finland

Acute abdomen

5.9

163.2

481

852

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.2

163.0

2214

12079

5770F

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICA RECIDIVANS]

+∞

156.8

150

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

4.2

151.6

625

1590

T90

ICPC

Diabetes non-insulin dependent

2.1

149.8

2111

11620

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

14.6

149.4

258

182

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

6.0

148.4

435

764

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.3

139.6

1539

7545

N07BB01

ATC

disulfiram; oral

4.0

137.8

600

1601

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

15.0

135.5

231

158

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

8.1

133.6

314

403

K86.8

ICD-10 Finland

Other specified diseases of pancreas

46.2

132.1

163

F10.25

ICD-10 Finland

Alcohol dependence continuous use

7.1

131.9

339

498

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.9

131.9

595

1636

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

11.9

130.5

247

214

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

22.2

129.1

191

D02

ICPC

Abdominal pain epigastric

3.7

123.9

582

1654

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

5.5

122.4

380

714

N02BE01

ATC

paracetamol; systemic, rectal

2.0

120.3

6527

56048

A10BA02

ATC

metformin; oral

1.9

120.2

2405

14917

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

119.6

1536

8004

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

119.0

2221

13425

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

6.4

114.0

315

511

P15

ICPC

Chronic alcohol abuse

4.8

113.3

398

858

F10.20

ICD-10 Finland

Alcohol dependence currently independent

5.7

113.2

341

617

K80.1

ICD-10 Finland

Calculus of gallbladder with other cholecystitis

5.5

111.7

346

648

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

6.4

103.7

287

466

JKA20

NOMESCO Finland

Cholecystectomy

4.5

102.6

389

906

N02AA05

ATC

oxycodone; systemic

2.1

101.7

1297

6686

J01DB01

ATC

cefalexin; oral

1.8

100.4

6099

52005

N06AX11

ATC

mirtazapine; oral

1.8

100.3

2400

15597

JLB28

NOMESCO Finland

Endoscopic internal drainage of pancreatic duct

76.5

99.5

113

A02BC05

ATC

esomeprazole; systemic

1.7

98.5

3053

21429

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.8

97.3

447

1241

N05AH04

ATC

quetiapine; oral

2.1

97.2

1281

6684

N05CF01

ATC

zopiclone; oral

1.7

95.7

2543

17013

UJF32

NOMESCO Finland

Coloscopy

1.8

95.2

2034

12698

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

11.8

94.6

179

155

C03CA01

ATC

furosemide; systemic

1.7

93.9

2356

15465

P01AB01

ATC

metronidazole; oral, rectal

1.7

93.3

2809

19460

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

93.0

2010

12576

F10.24

ICD-10 Finland

Alcohol depence active use

6.5

92.5

252

401

SPAT1262

SPAT

Handing over of treatment supplies

1.9

92.2

1549

8873

N05BA01

ATC

diazepam; systemic, rectal

2.1

90.7

1139

5804

A02BC01

ATC

omeprazole; systemic

1.8

89.1

2169

14056

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.8

87.8

607

2266

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

10.6

87.6

175

169

D01

ICPC

Abdominal pain/cramps general

2.4

87.4

789

3434

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

86.7

1260

6808

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

86.5

4423

35055

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.3

86.4

886

4110

N03AX16

ATC

pregabalin; oral

1.8

84.4

1800

11150

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.3

84.0

891

4194

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

17.9

83.3

132

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

18.3

82.8

130

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

7.1

82.0

209

303

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

80.8

1521

9021

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

79.3

1300

7330

JLD12

NOMESCO Finland

Endoscopic drainage of pancreatic pseudocyst

76.0

79.3

TJK01

NOMESCO Finland

Laparoscopic cholangiography

9.1

79.1

171

191

F10.09

ICD-10 Finland

Alcohol intoxication UNS

4.6

77.7

281

623

R11

ICD-10 Finland

Nausea and vomiting

2.6

77.6

631

2587

K70.1

ICD-10 Finland

Alcoholic hepatitis

10.8

77.2

152

143

N05BA02

ATC

chlordiazepoxide; systemic

4.0

76.1

323

835

TPH07

NOMESCO Finland

Cathetrisation of artery

2.2

75.7

896

4423

E13

ICD-10 Finland

Other specified diabetes mellitus

29.0

75.6

103

J01MA02

ATC

ciprofloxacin; systemic

1.6

75.5

2972

21767

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

73.9

760

3514

K81.0

ICD-10 Finland

Acute cholecystitis

4.6

73.4

266

591

TKC20

NOMESCO Finland

Catheterisation of bladder

2.4

73.3

687

3035

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.1

73.2

946

4846

E13.8

ICD-10 Finland

Other specified diabetes mellitus, with unspecified complications

31.0

73.2

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.8

72.9

330

903

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.4

72.9

693

3084

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.9

72.7

248

517

N05BA04

ATC

oxazepam; oral

1.7

72.2

1781

11455

JLB35

NOMESCO Finland

Transduodenal endoscopic extraction of foreign body from pancreatic duct

129.6

72.0

K86.2

ICD-10 Finland

Cyst of pancreas

9.3

71.3

152

166

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

6.0

71.0

203

344

E13.7

ICD-10 Finland

Other specified diabetes mellitus, with multiple complications

88.7

71.0

WX002

NOMESCO Finland

Sedation and analgesia

1.8

70.7

1486

9089

N06AB04

ATC

citalopram; systemic

1.8

70.1

1572

9809

B01AB05

ATC

enoxaparin; parenteral

1.6

69.0

2225

15387

K92.0

ICD-10 Finland

Haematemesis

4.1

68.3

283

716

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.8

68.2

305

826

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

5.7

67.9

204

368

WX402

NOMESCO Finland

General anaesthesia

1.9

67.9

1218

7055

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

6.0

67.7

193

326

P16

ICPC

Acute alcohol abuse

5.2

67.7

218

427

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.8

67.3

1251

7330

A02BC03

ATC

lansoprazole; oral

1.6

67.3

2164

14936

K80.3

ICD-10 Finland

Calculus of bile duct with cholangitis

8.3

67.2

153

187

A05AA02

ATC

ursodeoxycholic acid; oral

6.1

66.5

189

318

N05CD07

ATC

temazepam; oral

1.9

66.1

1041

5750

A02BA02

ATC

ranitidine; systemic

1.7

65.8

1558

9856

5770C

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA NONALCOHOLICA RECIDIVANS]

+∞

65.7

K86.0

ICD-10 Finland

Alcohol-induced chronic pancreatitis

63.1

64.5

H02AB06

ATC

prednisolone; systemic

1.5

64.2

3362

26018

K80.8

ICD-10 Finland

Other cholelithiasis

5.2

63.9

207

408

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

4.9

63.8

218

456

A10AE05

ATC

insulin detemir; parenteral

2.6

63.7

503

2022

T89

ICPC

Diabetes insulin dependent

3.1

63.5

366

1207

A06AD11

ATC

lactulose; oral

1.8

62.9

1158

6747

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

5.2

62.4

203

402

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

61.8

2143

15016

JLC50

NOMESCO Finland

Atypical pancreatectomy

211.6

61.2

K81.9

ICD-10 Finland

Cholecystitis, unspecified

5.7

60.7

181

324

K29.2

ICD-10 Finland

Alcoholic gastritis

15.9

60.1

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

59.6

941

5187

UJD02

NOMESCO Finland

Gastroscopy

2.7

59.1

440

1709

K85.3

ICD-10 Finland

Drug-induced acute pancreatitis

+∞

58.4

5770B

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA NONALCOHOLICA HAEMORRHAGICA]

+∞

58.4

57700

ICD-8 Finland

Diseases of pancreas, Pancreatitis acuta haemorrhagica

+∞

57.3

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

56.7

3225

25163

AA1AD

NOMESCO Finland

CT of head and brain

1.6

56.2

1766

12014

R50.9

ICD-10 Finland

Fever, unspecified

1.8

56.1

1037

6032

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.8

55.4

376

1381

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.5

55.2

452

1852

WX892

NOMESCO Finland

Monitored bed care

2.1

55.0

638

3103

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

7.3

54.8

135

187

WX110

NOMESCO Finland

Local anesthesy

1.5

54.7

4702

39769

UJK12

NOMESCO Finland

Peroral cholangioscopy

19.5

54.3

JAH00

NOMESCO Finland

Laparotomy

3.3

54.0

282

865

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

5.4

53.8

167

314

J01DA01

ATC

[U] cefalexin; systemic

1.4

53.4

4438

37198

K80.4

ICD-10 Finland

Calculus of bile duct with cholecystitis

6.1

53.2

149

247

R4110

NOMESCO Finland

Physiotherapy

1.6

53.1

1891

13238

C07AB07

ATC

bisoprolol; oral

1.5

52.7

3451

27565

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.5

52.6

435

1791

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

52.5

2015

14354

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

4.6

51.7

186

411

K30

ICD-10 Finland

Functional dyspepsia

2.0

51.6

728

3833

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.7

51.6

377

1447

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

4.4

51.3

194

451

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

6.0

51.2

145

244

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.6

50.9

394

1561

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

50.8

1203

7544

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

4.9

50.6

170

350

N06AX16

ATC

venlafaxine; oral

1.8

50.1

897

5150

5770E

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICAHAEMORRHAGICA]

+∞

50.0

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

50.0

1908

13548

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.6

49.6

386

1535

R53

ICD-10 Finland

Malaise and fatigue

1.6

49.2

1384

9099

N05AB01

ATC

dixyrazine; systemic

4.8

48.9

169

359

L04AX01

ATC

azathioprine; systemic

2.7

48.7

357

1373

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

6.1

48.7

136

225

SPAT1254

SPAT

Administration of medicine

1.7

48.3

1039

6324

C08CA01

ATC

amlodipine; oral

1.5

47.8

2574

19650

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.7

47.6

352

1359

57710

ICD-8 Finland

Diseases of pancreas, Pancreatitis chronica recidivans

470.6

47.4

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

5.5

46.6

141

258

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

46.4

822

4695

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

46.3

1386

9243

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

7.0

46.1

117

170

C07AA05

ATC

propranolol; systemic

1.6

46.0

1220

7878

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

46.0

786

4433

N03AX12

ATC

gabapentin; oral

1.7

46.0

1067

6635

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

5.1

45.6

149

298

Z72.1

ICD-10 Finland

Alcohol use

4.5

45.2

165

371

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

44.6

772

4372

N06AX21

ATC

duloxetine; oral

1.9

44.5

714

3936

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

44.1

2079

15386

JLC30

NOMESCO Finland

Pancreatoduodenectomy

8.2

44.0

100

123

JLB42

NOMESCO Finland

Transduodenal endoscopic dilatation of pancreatic duct

96.6

43.8

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

43.8

3373

27429

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.5

43.2

208

600

A10BH01

ATC

sitagliptin; oral

1.9

43.2

735

4136

JN4BD

NOMESCO Finland

Extensive body CT

1.8

43.0

833

4893

R06.0

ICD-10 Finland

Dyspnoea

1.5

42.8

1689

12007

JLC10

NOMESCO Finland

Distal pancreatectomy

15.2

42.6

ZX120

NOMESCO Finland

Intravenous

1.9

42.6

703

3914

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

42.3

1210

7957

SPAT1263

SPAT

Sampling

1.4

42.1

2811

22218

K92.1

ICD-10 Finland

Melaena

2.3

42.0

427

1949

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

5.2

41.9

133

258

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.2

41.6

430

1977

JN4AD

NOMESCO Finland

Body CT examination

2.0

41.1

591

3126

N05AA02

ATC

levomepromazine; systemic

2.5

41.1

350

1464

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

8.8

40.9

102

5772A

ICD-9 Finland

Diseases of pancreas, Cyst and pseudocyst of pancreas[CYSTA ET PSEUDOCYSTA PANCREATIS]

77.2

40.9

TK800

NOMESCO Finland

Hemodialysis

3.2

40.9

223

708

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

9.4

40.7

M54.5

ICD-10 Finland

Low back pain

1.4

40.3

2108

15871

V03AA01

ATC

3.5

40.1

192

552

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

40.0

1192

7914

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.7

39.9

284

1074

JK3SB

NOMESCO Finland

Endoscopic retrorade cholangiography

17.2

39.7

N06AB10

ATC

escitalopram; oral

1.6

39.6

1194

7942

57701

ICD-8 Finland

Diseases of pancreas, Pancreatitis acuta cum abscessu

+∞

39.6

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

39.3

887

5456

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.2

38.9

435

2073

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.3

38.8

377

1684

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

38.5

974

6182

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

9.7

38.5

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

5.2

38.3

122

238

E87.6

ICD-10 Finland

Hypokalaemia

2.9

38.3

249

891

5353A

ICD-9 Finland

Gastritis and duodenitis, Alcoholic gastritis

25.4

37.9

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

10.4

37.8

M04AA01

ATC

allopurinol; systemic

1.6

37.6

1008

6497

A07EC02

ATC

mesalazine; oral, rectal

2.2

37.3

412

1951

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

37.1

1226

8331

A03DA02

ATC

pitofenone and analgesics; systemic

3.3

37.0

190

577

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.0

37.0

226

776

S18

ICPC

Laceration/cut

1.4

37.0

2826

22724

SPAT1265

SPAT

Breathalyser

5.0

36.9

121

244

A41.9

ICD-10 Finland

Sepsis, unspecified

2.5

36.9

307

1268

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.5

36.7

299

1218

E13.4

ICD-10 Finland

Other specified diabetes mellitus, with neurological complications

100.5

36.7

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.7

36.5

259

976

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

15.0

36.5

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

36.4

1152

7747

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

6.2

36.0

162

M79.6

ICD-10 Finland

Pain in limb

1.4

35.9

2234

17301

WX872

NOMESCO Finland

Intensive care

2.1

35.7

422

2058

J01FF01

ATC

clindamycin; systemic

1.4

35.6

1819

13570

H02AB07

ATC

prednisone; oral

1.6

35.5

981

6369

WX882

NOMESCO Finland

High dependency care

2.8

35.3

239

876

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.7

35.2

767

4659

N06AB06

ATC

sertraline; oral

1.8

35.2

654

3782

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

34.9

874

5524

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.6

34.8

257

993

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.1

34.8

433

2161

JLT00

NOMESCO Finland

Extracorporeal shock wave lithotripsy of pancreatic duct

180.8

34.8

XF600

NOMESCO Finland

Bloodpressure measurement

2.0

34.7

469

2420

N07BA03

ATC

varenicline; oral

2.2

34.4

361

1673

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

3.0

34.4

211

727

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.7

34.1

245

931

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

34.1

641

3718

JN4CD

NOMESCO Finland

Very extensive body CT

2.3

33.9

318

1397

A10BB12

ATC

glimepiride; oral

1.9

33.9

563

3131

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.0

33.9

481

2526

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

5.3

33.6

104

197

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.5

33.4

272

1111

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.9

33.3

508

2741

EBA00

NOMESCO Finland

Extraction of tooth

1.4

33.2

2094

16211

K50.8

ICD-10 Finland

Other Crohn disease

3.9

33.1

139

359

5771C

ICD-9 Finland

Diseases of pancreas, Chronic pancreatitis[PANCREATITIS CHRONICA ALCOHOLICA RECIDIVANS]

170.7

32.7

A46

ICD-10 Finland

Erysipelas

1.6

32.7

987

6545

K29.7

ICD-10 Finland

Gastritis, unspecified

2.5

32.5

273

1133

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

8.4

32.5

C09AA05

ATC

ramipril; oral

1.4

32.3

1753

13189

A10BH05

ATC

linagliptin; oral

2.1

32.1

366

1758

K50.9

ICD-10 Finland

Crohn disease, unspecified

3.9

31.9

133

341

C03DA01

ATC

spironolactone; oral

1.7

31.7

753

4680

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

31.5

2561

20652

N06AB03

ATC

fluoxetine; oral

1.7

31.4

783

4936

D06

ICPC

Abdominal pain localized other

1.9

31.4

471

2525

D13.6

ICD-10 Finland

Benign neoplasm: Pancreas

7.1

31.2

109

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

3.3

31.1

165

515

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

31.1

2569

20758

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

31.0

681

4138

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.3

31.0

290

1273

N05BA12

ATC

alprazolam; oral

1.7

30.8

675

4101

K70.4

ICD-10 Finland

Alcoholic hepatic failure

7.4

30.7

101

TJK00

NOMESCO Finland

Intraoperative cholangiography

5.6

30.6

161

J01MA14

ATC

moxifloxacin; systemic

1.7

30.3

624

3720

K70.0

ICD-10 Finland

Alcoholic fatty liver

5.4

30.3

171

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.2

30.2

321

1498

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

30.1

679

4155

N06AA09

ATC

amitriptyline; systemic

1.7

30.1

661

4017

JAH01

NOMESCO Finland

Laparoscopy

2.3

30.1

284

1252

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.3

30.1

294

1317

S06.0

ICD-10 Finland

Concussion

1.7

30.0

661

4021

A07EA06

ATC

budesonide; oral, local oral

2.5

29.9

243

990

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

12.7

29.7

N06AA12

ATC

doxepin; systemic

2.0

29.6

381

1928

1280

FHL

Endoscopic retrograde cholangiography and pancreaticography

23.4

29.5

K51.5

ICD-10 Finland

Left sided colitis

2.6

29.4

216

833

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

29.2

1960

15265

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

4.3

29.0

109

255

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

28.8

521

2978

WVA20

NOMESCO Finland

Medicine administration

2.8

28.8

187

668

JMA10

NOMESCO Finland

Transabdominal total splenectomy

6.2

28.8

126

A10BK03

ATC

empagliflozin; oral

1.8

28.5

497

2807

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

28.5

1614

12196

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.1

28.5

159

516

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

28.4

717

4530

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

28.4

613

3705

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.9

28.3

442

2403

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.2

28.3

313

1487

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

28.0

487

2747

C10AC01

ATC

colestyramine; oral

2.7

27.8

199

756

JLD22

NOMESCO Finland

Endoscopic drainage of pancreatic pseudocyst to jejunum

77.9

27.7

JL5CM

NOMESCO Finland

Bile and pancreas ducts extensive MRI examination with 3 Tesla magnet

32.9

27.7

5771D

ICD-9 Finland

Diseases of pancreas, Chronic pancreatitis[PANCREATITIS CHRONICA ALCOHOLICA NUD]

145.5

27.6

R03AC02

ATC

salbutamol; inhalant

1.3

27.6

3305

28073

A10AE06

ATC

insulin degludec; parenteral

2.5

27.5

219

884

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

7.2

27.4

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

7.8

27.3

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.2

27.2

297

1400

N05CF02

ATC

zolpidem; oral

1.5

27.1

1071

7530

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

27.1

2360

19119

R4190

NOMESCO Finland

Nutritional therapy

2.5

27.0

226

938

WX290

NOMESCO Finland

Other blockade of nerve

1.3

26.7

2624

21634

WX004

NOMESCO Finland

Patient-controlled sedation

6.3

26.7

116

57719

ICD-8 Finland

Diseases of pancreas, Pancreatitis chronica NUD

140.5

26.6

JAH33

NOMESCO Finland

Opening of laparostomy

14.1

26.5

B03BA03

ATC

hydroxocobalamin; parenteral

1.9

26.5

416

2269

E86

ICD-10 Finland

Volume depletion

2.6

26.5

194

746

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

26.5

502

2913

A28

ICPC

Limited function/disability NOS

1.5

26.4

975

6755

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

26.3

515

3020

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

26.3

2061

16412

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

26.1

1345

9966

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

3.5

26.1

126

368

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

26.0

2473

20271

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

26.0

965

6694

130

Kela drug reimbursment

Malignant tumour

1.7

26.0

596

3664

E13.3

ICD-10 Finland

Other specified diabetes mellitus, with ophthalmic complications

60.2

25.9

L28

ICPC

Limited function/disability (L)

1.5

25.9

973

6762

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

3.4

25.9

130

391

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.4

25.8

218

909

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

4.2

25.7

238

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.5

25.5

121

348

A01

ICPC

Pain general/multiple sites

1.8

25.5

467

2680

N03AF01

ATC

carbamazepine; oral, rectal

1.9

25.5

366

1930

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

25.4

1480

11211

XCK10

NOMESCO Finland

Photography of fundus of eye

1.6

25.3

682

4375

205

Kela drug reimbursment

Chronic hypertension

1.3

25.3

1960

15558

N06AX03

ATC

mianserin; oral

2.0

25.3

329

1672

E0000UV

ATC

1.3

25.3

2415

19790

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.0

25.2

341

1759

SPAT1260

SPAT

Consultation of another employee

1.5

25.2

1105

7933

B01AB10

ATC

tinzaparin; parenteral

1.8

25.2

451

2570

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

25.1

305

1507

S22.3

ICD-10 Finland

Fracture of rib

1.8

25.0

457

2623

K29.1

ICD-10 Finland

Other acute gastritis

3.4

25.0

123

365

K50.0

ICD-10 Finland

Crohn disease of small intestine

3.4

24.9

123

366

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

8.0

24.8

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

7.4

24.8

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

24.6

648

4135

E13.1

ICD-10 Finland

Other specified diabetes mellitus, with ketoacidosis

32.1

24.6

S01.0

ICD-10 Finland

Open wound of scalp

1.7

24.4

520

3127

A02BA04

ATC

nizatidine; systemic

1.7

24.4

540

3286

N05BE01

ATC

buspirone; oral

2.4

24.3

217

931

I81

ICD-10 Finland

Portal vein thrombosis

7.4

24.3

R51.80

ICD-10 Finland

Headache

1.5

24.2

794

5348

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.0

24.2

335

1743

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

24.1

398

2208

W19

ICD-10 Finland

Unspecified fall

1.6

24.1

602

3789

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.8

24.1

160

583

J01FA06

ATC

roxithromycin; oral

1.3

24.0

2575

21404

E87.2

ICD-10 Finland

Acidosis

5.6

24.0

125

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.4

24.0

117

345

C09AA02

ATC

enalapril; systemic

1.4

24.0

1357

10212

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

23.9

1082

7806

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.9

23.9

346

1832

K02.1

ICD-10 Finland

Caries of dentine

1.3

23.9

3519

30503

Z71.8

ICD-10 Finland

Other specified counselling

1.4

23.9

1358

10228

JLB12

NOMESCO Finland

Transduodenal endoscopic incision of pancreatic duct orifice

22.8

23.8

L03

ICPC

Low back symptom/complaint

1.4

23.7

1388

10505

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

23.7

467

2743

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

23.7

1661

12956

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

23.7

864

5961

5771A

ICD-9 Finland

Diseases of pancreas, Chronic pancreatitis[PANCREATITIS CHRONICA NONALCOHOLICA RECIDIVANS]

240.6

23.6

K80

ICD-10 Finland

Cholelithiasis

3.8

23.6

102

272

C10AB05

ATC

fenofibrate; oral

2.8

23.6

157

573

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

23.6

488

2912

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.9

23.5

354

1898

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

3.8

23.4

102

274

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.2

23.3

250

1171

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

23.3

600

3806

D10

ICPC

Vomiting

2.1

23.2

282

1393

N03AX09

ATC

lamotrigine; oral

2.1

23.2

273

1333

JK3NB

NOMESCO Finland

Percutaneous transhepatic cholangiography

9.3

23.2

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

23.1

244

1138

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

23.0

533

3281

K56.7

ICD-10 Finland

Ileus, unspecified

2.9

22.8

140

486

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

22.8

696

4603

30320

ICD-8 Finland

Alcoholism, Alcoholic addiction

4.3

22.8

203

N05AF03

ATC

chlorprothixene; systemic

2.4

22.8

192

802

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

22.6

450

2653

JDE00

NOMESCO Finland

Gastrojejunostomy

11.4

22.6

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

22.3

459

2734

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.8

22.3

373

2081

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

22.3

1053

7656

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.0

22.2

292

1489

D11

ICPC

Diarrhoea

1.6

22.2

577

3668

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

2.1

22.1

246

1171

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

21.9

431

2529

XX9TE

NOMESCO Finland

Compementary ultrasound examination

4.9

21.9

148

JLD10

NOMESCO Finland

Anastomosis of pancreatic pseudocyst to stomach

+∞

21.9

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

5.2

21.8

132

SPAT1255

SPAT

Intravenous administration of medicine

1.7

21.7

438

2588

P01

ICPC

Feeling anxious/nervous/tense

1.7

21.7

440

2608

SPAT1227

SPAT

Substance abuse rehabilitation

4.9

21.6

146

K76.9

ICD-10 Finland

Liver disease, unspecified

3.4

21.6

106

315

L17

ICPC

Foot/toe symptom/complaint

1.4

21.5

1478

11468

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

21.5

912

6488

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.2

21.3

217

995

R03BB04

ATC

tiotropium bromide; inhalant

1.5

21.3

675

4504

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.8

21.2

140

511

J02AC01

ATC

fluconazole; systemic

1.3

21.1

2107

17271

N17.8

ICD-10 Finland

Other acute renal failure

3.5

21.1

100

289

K65.0

ICD-10 Finland

Acute peritonitis

3.4

21.1

103

305

E13.2

ICD-10 Finland

Other specified diabetes mellitus, with renal complications

33.9

21.1

309

Kela drug reimbursment

Nalmefene and naltrexone

6.4

21.0

C07AB02

ATC

metoprolol; systemic

1.4

21.0

1362

10463

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.2

20.9

111

350

S97

ICPC

Chronic ulcer skin

1.8

20.9

366

2070

B01AA03

ATC

warfarin; systemic

1.4

20.8

1402

10837

GBB00

NOMESCO Finland

Tracheostomy

3.3

20.8

104

314

E66.8

ICD-10 Finland

Other obesity

1.9

20.8

292

1532

E14.1

ICD-10 Finland

Unspecified diabetes mellitus, with ketoacidosis

11.6

20.7

J01CA04

ATC

amoxicillin; systemic

1.3

20.6

5394

49752

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.1

20.5

247

1219

6663

FHL

Cholecystectomy and cholangiography

3.1

20.4

117

387

H02AB04

ATC

methylprednisolone; systemic

1.5

20.4

882

6294

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.4

20.4

170

705

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

3.6

20.4

256

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.9

20.3

123

423

E78.11

ICD-10 Finland

Other hypertriglyceridemia

5.1

20.3

126

R02

ICPC

Shortness of breath/dyspnoea

1.5

20.3

704

4795

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.6

20.2

146

561

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.0

20.2

248

1232

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

19.9

1740

13979

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.4

19.7

173

740

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

3.4

19.7

295

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

6.5

19.7

JKB20

NOMESCO Finland

Intraoperative cholangioscopy

11.7

19.7

JLD00

NOMESCO Finland

Pancreaticojejunostomy

73.7

19.7

57792

ICD-8 Finland

Diseases of pancreas, Cysta pancreatis

73.7

19.7

SPAT1301

SPAT

No procedures

1.3

19.7

1990

16312

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.2

19.7

192

865

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

19.6

918

6653

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

19.5

1678

13442

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

5.5

19.5

107

WZC30

NOMESCO Finland

Teaching

1.5

19.5

833

5927

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

19.5

594

3929

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.3

19.4

293

R07.3

ICD-10 Finland

Other chest pain

1.6

19.4

560

3652

P18

ICPC

Medication abuse

5.6

19.4

100

53502

ICD-8 Finland

Gastritis and duodenitis, Gastritis acuta NUD

4.7

19.4

142

N06AB05

ATC

paroxetine; oral

1.8

19.3

360

2080

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

19.3

852

6103

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.6

19.2

459

2848

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

19.2

1334

10349

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

5.0

19.2

126

J01AA02

ATC

doxycycline; systemic

1.3

19.2

5361

49567

D98

ICPC

Cholecystitis/cholelithiasis

5.0

19.2

122

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.3

19.1

177

776

K50.1

ICD-10 Finland

Crohn disease of large intestine

3.3

19.1

292

M03BX02

ATC

tizanidine; oral

1.2

19.0

3937

35153

R60.0

ICD-10 Finland

Localized oedema

1.5

18.9

663

4524

E87.5

ICD-10 Finland

Hyperkalaemia

2.7

18.9

130

486

E14.8

ICD-10 Finland

Unspecified diabetes mellitus, with unspecified complications

6.5

18.9

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.5

18.9

149

603

W10

ICD-10 Finland

Fall on and from stairs and steps

1.9

18.9

302

1659

SPAT1240

SPAT

Therapeutic discussion

1.6

18.9

522

3370

E89.1

ICD-10 Finland

Postprocedural hypoinsulinaemia

34.4

18.9

N19

ICD-10 Finland

Unspecified kidney failure

2.0

18.8

233

1162

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.5

18.8

150

610

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

18.8

1524

12102

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

18.7

877

6350

RS220

NOMESCO Finland

3.3

18.7

281

A11CC03

ATC

alfacalcidol; systemic

2.3

18.6

168

728

JLW96

NOMESCO Finland

Other operation on pancreas

190.4

18.5

E14

ICD-10 Finland

Unspecified diabetes mellitus

7.1

18.5

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.5

18.5

142

566

B81

ICPC

Anaemia vit B12/folate deficiency

1.9

18.5

257

1343

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

18.5

1346

10511

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

18.4

1522

12111

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

3.5

18.4

242

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

5.1

18.4

115

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

3.8

18.4

212

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

4.4

18.1

152

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

18.1

628

4278

A02BA03

ATC

famotidine; systemic

1.9

18.0

268

1436

N06AX05

ATC

trazodone; oral

2.4

18.0

158

676

S10

ICPC

Boil/carbuncle

1.8

18.0

326

1865

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

18.0

4479

40697

WX730

NOMESCO Finland

Conventional respirator

2.6

18.0

129

496

JL5BM

NOMESCO Finland

Bile and pancreas ducts MRI examination with 3 Tesla magnet

32.9

17.9

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

17.9

794

5687

M25.5

ICD-10 Finland

Pain in joint

1.3

17.8

1575

12652

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

17.8

701

4905

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

5.8

17.7

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.5

17.7

144

593

N30.0

ICD-10 Finland

Acute cystitis

1.5

17.7

704

4935

WW500

NOMESCO Finland

Blood transfusion

1.9

17.6

256

1361

F10.22

ICD-10 Finland

Alcohol dependence is currently on clinically controlled discontinuation medication

6.6

17.6

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

17.6

939

6961

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.4

17.5

145

601

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.4

17.5

154

659

WX704

NOMESCO Finland

Intubation

1.6

17.5

425

2652

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

3.5

17.4

227

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

17.4

412

2554

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.6

17.3

124

477

A03

ICPC

Fever

1.4

17.1

807

5848

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

17.1

1142

8788

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.0

17.0

211

1054

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

17.0

617

4242

A41.8

ICD-10 Finland

Other specified sepsis

2.6

17.0

126

494

L86

ICPC

Back syndrome with radiating pain

1.8

17.0

315

1816

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

3.0

17.0

322

C10AA01

ATC

simvastatin; oral

1.2

16.9

2929

25517

E16.19

ICD-10 Finland

Other specified hypoglycaemia

6.2

16.9

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

16.8

961

7206

Z53.8

ICD-10 Finland

Procedure not carried out for other reasons

6.3

16.8

E13.0

ICD-10 Finland

Other specified diabetes mellitus, with coma

63.4

16.7

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.7

16.7

368

2234

A12BA01

ATC

potassium chloride; oral

1.8

16.7

289

1631

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3024139) IgG subclass 3 [Mass/volume] in Serum

459

635

7.58

314.85

1.6

1.3

g/l

0.4

0.04

210

464

(3027135) IgG subclass 1 [Mass/volume] in Serum

459

636

7.56

314.41

1.6

1.3

g/l

6.1

6.9

2.91

212

463

(3028192) IgG subclass 2 [Mass/volume] in Serum

459

636

7.56

314.41

1.6

1.3

g/l

2.9

0.07

210

467

(4062490)

460

640

7.53

313.95

1.6

1.3

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

4855

30682

2.32

311.88

8.3

4.9

g/l

33.5

35.3

74.13

4589

28416

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4015

22521

2.45

307.65

5.4

3.2

u/l

47.9

35.0

4.18

3827

21268

(3023368) Bacteria identified in Blood by Culture

3850

20146

2.64

307.65

6.3

4.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5016

21927

4.04

307.65

6.2

2.4

u/l

118.7

56.2

38.95

4768

20250

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1211

1911

7.20

307.65

1.7

1.4

ug/g

214.7

275.4

10.08

737

1124

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1866

6612

3.32

307.65

3.6

2.2

g/l

0.2

8.46

1779

6123

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6134

36478

3.31

307.65

12.0

6.2

umol/l

13.3

11.9

7.82

5927

34618

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2012

6381

3.80

307.65

6.7

2.3

u/l

175.4

33.5

3.22

1814

5484

(3024980) IgG subclass 4 [Mass/volume] in Serum

940

1001

10.41

307.65

1.9

1.5

g/l

0.7

0.9

1.85

608

781

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2437

7927

3.88

307.65

5.3

2.7

umol/l

10.3

8.9

2.00

2193

6927

(3032080) INR in Blood by Coagulation assay

4731

29830

2.29

302.05

11.7

9.6

inr

1.2

1.3

6.66

1397

8370

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

928

2541

3.97

296.13

4.0

3.5

u/ml

677.0

2323.1

0.83

821

2190

(3013826) Glucose [Moles/volume] in Serum or Plasma

5884

41911

2.25

261.72

8.3

4.8

mmol/l

7.4

6.8

51.64

5674

39386

(3017315) Amylase [Enzymatic activity/volume] in Urine

303

315

9.93

261.25

1.6

1.2

u/l

948.2

260.4

3.20

259

293

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5141

35049

2.14

250.88

10.0

6.9

mmol/l

1.2

18.31

4387

29530

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4770

31764

2.11

245.66

9.2

6.2

mmol/l

1.2

17.24

4481

28737

(3033658) Prothrombin time (PT) actual/Normal

3170

18103

2.18

244.09

7.9

4.0

85.4

88.0

7.03

3085

17656

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6947

53893

2.44

239.45

14.8

7.5

u/l

95.1

78.6

67.06

6730

50707

(3014576) Chloride [Moles/volume] in Serum or Plasma

1942

9288

2.40

226.24

11.3

7.3

mmol/l

103.7

104.5

9.54

1905

9091

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

590

1450

4.29

216.43

3.7

3.5

u/ml

844.2

751.4

0.07

550

1341

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1633

7390

2.49

213.69

4.1

4.2

ug/l

9.4

23.3

3.55

1353

6091

(3023183) Ammonium ion [Moles/volume] in Plasma

601

1561

4.06

204.46

3.7

2.7

umol/l

37.2

34.4

1.39

521

1326

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1903

9435

2.30

201.36

7.6

5.9

mmol/l

1.0

0.36

1796

8773

(3005719) IgG [Mass/volume] in Serum or Plasma

1243

5073

2.69

200.50

2.6

g/l

10.6

0.02

1014

4653

(3044640) Blood type and Crossmatch panel - Blood

3522

22107

2.00

200.40

3.7

2.5

—

(3018418) pH of Serum or Plasma

3308

20596

1.98

190.12

5.5

4.1

7.4

0.15

717

3932

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1203

5100

2.58

178.38

1.8

1.6

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2157

11760

2.11

177.06

4.4

3.4

mmol/l

0.8

20.05

2042

10982

(3020779) Urea [Moles/volume] in Serum or Plasma

1449

6767

2.37

173.73

9.4

7.3

mmol/l

10.0

10.3

0.51

1384

6433

(3002582) Erythrocytes [#/volume] in Urine

3376

21770

1.90

169.78

4.0

3.3

e6/l

38.4

99.7

5.41

2756

16857

(3014111) Lactate [Moles/volume] in Serum or Plasma

1394

6506

2.36

166.85

9.8

7.2

mmol/l

1.5

1.4

2.44

1341

6225

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4557

32461

1.85

165.83

5.4

4.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

5829

45026

1.89

161.80

5.7

4.5

e6/l

680.1

1596.7

1.52

668

(3013650) Neutrophils [#/volume] in Blood by Automated count

5304

39831

1.85

160.33

11.5

9.1

e9/l

4.8

4.2

47.03

4714

34634

(3030467) Casts [#/volume] in Urine by Automated count

3112

19950

1.87

156.15

4.0

3.2

e6/l

0.5

0.4

0.09

2492

15119

(3000850) Epithelial cells [#/volume] in Urine

2535

15210

1.94

155.81

3.2

2.6

e6/l

5.9

4.6

4.74

2278

13317

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2740

16878

1.91

155.50

3.5

2.4

—

(3018095) Leukocytes [#/volume] in Urine

3676

24907

1.82

153.58

4.6

3.8

e6/l

73.8

95.3

0.98

2873

18066

(3042936) Bacteria identified in Isolate by Culture

1877

10225

2.07

151.30

2.7

2.1

—

(3026782) Osmolality of Urine

2389

14167

1.95

151.27

3.3

2.8

mosm/kgh2o

525.5

560.1

10.88

2109

12077

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

319

637

5.16

150.40

1.7

1.3

—

(36304419) Bacteria [Presence] in Urine

2997

19277

1.85

146.64

3.9

3.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

314

641

5.04

144.30

1.4

1.3

nmol/l

1.1

1.5

8.20

285

575

(3000991) Gas panel - Venous blood

1287

6156

2.28

143.86

12.3

8.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2028

11798

1.94

133.38

2.1

1.8

—

(3012544) pH of Venous blood

1399

7134

2.15

132.59

6.0

3.8

7.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

561

1843

3.18

132.57

1.5

1.2

titre

69.8

167.7

1.66

154

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1358

6865

2.16

131.53

6.0

3.8

kpa

5.8

1.31

1317

6653

(3002032) Base excess in Venous blood by calculation

1353

6843

2.16

130.83

6.0

3.8

mmol/l

1.5

1.9

2.88

1116

5516

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5756

45710

1.77

129.61

6.3

3.1

u/l

96.9

51.4

61.86

5428

42447

(3009508) Creatinine [Moles/volume] in Urine

3316

22655

1.75

127.99

3.7

3.2

mmol/l

7.2

7.9

14.95

2756

18986

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3874

27707

1.72

126.29

4.9

3.8

ng/l

47.8

79.4

0.82

2952

19704

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

465

1406

3.44

125.62

2.4

1.7

nmol/l

0.7

0.8

4.03

383

1169

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1538

8315

2.03

123.90

2.6

1.8

1.7

1.5

17.08

1315

7257

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2716

17673

1.78

123.13

2.6

2.2

mg/l

3.0

0.47

2347

15036

(3034770) Mitochondria Ab [Titer] in Serum

544

1833

3.10

122.97

1.4

1.2

titre

881.8

1012.0

0.10

(3020682) Albumin/Creatinine [Ratio] in Urine

3297

22789

1.72

119.96

4.6

4.0

mg/mmol

16.0

9.2

6.37

2194

14768

(3012516) Albumin [Mass/volume] in Urine

3152

21622

1.72

117.20

3.7

3.3

mg/l

430.3

400.7

0.13

2143

14032

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

811

3469

2.48

115.57

6.4

4.0

mmol/l

23.9

24.1

0.47

733

3107

(42870588) Differential panel, method unspecified - Blood

3378

23788

1.69

112.77

7.3

5.9

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1894

11395

1.85

109.30

3.1

2.5

umol/l

11.9

13.0

8.00

1759

10554

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

940

4397

2.28

109.05

9.1

7.5

mmol/l

24.4

24.8

1.93

927

4359

(40758558) Short blood count panel - Blood

2630

17434

1.73

108.95

8.7

6.9

—

(3019069) Monocytes/100 leukocytes in Blood

4317

32579

1.65

108.79

7.9

6.4

8.7

8.8

2.00

4081

30433

(3006504) Eosinophils/100 leukocytes in Blood

4296

32403

1.64

108.31

7.6

6.1

2.8

2.9

2.20

4044

30150

(3026008) Bacteria identified in Urine by Culture

2911

19878

1.70

107.91

3.5

3.2

—

(3022096) Basophils/100 leukocytes in Blood

4181

31460

1.63

105.34

7.7

6.1

0.6

0.7

2.92

3935

29283

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1684

9885

1.87

104.54

3.1

2.6

22.2

22.8

0.92

1456

8404

(3006315) Basophils [#/volume] in Blood

4516

34690

1.63

104.19

7.5

5.9

e9/l

0.0

1.70

3950

29845

(3019198) Lymphocytes [#/volume] in Blood

4591

35479

1.62

102.78

7.6

5.9

e9/l

1.9

0.27

4077

31079

(3001604) Monocytes [#/volume] in Blood

4486

34516

1.62

101.89

7.5

5.8

e9/l

0.6

12.24

3935

29673

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1764

10584

1.84

101.79

3.1

2.5

g/l

2.2

2.3

4.13

1631

9794

(3002030) Lymphocytes/100 leukocytes in Blood

4366

33396

1.62

101.40

7.8

6.2

25.4

27.2

23.07

4107

30989

(3024354) Oxygen [Partial pressure] in Venous blood

1097

5612

2.09

101.14

4.9

3.2

kpa

4.7

4.6

1.30

1055

5418

(3015377) Calcium [Moles/volume] in Serum or Plasma

3260

23221

1.65

101.04

3.9

3.4

mmol/l

2.3

2.4

14.99

2893

20155

(3003396) Base excess in Arterial blood by calculation

1514

8676

1.90

100.90

10.8

7.4

mmol/l

0.7

1.0

1.98

1230

6722

(3018010) Neutrophils/100 leukocytes in Blood

4300

32863

1.61

99.49

7.5

5.9

59.5

57.7

19.31

4059

30642

(3027801) Oxygen [Partial pressure] in Arterial blood

1513

8707

1.89

99.38

10.8

7.4

kpa

11.8

12.2

2.46

1444

8287

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1512

8710

1.89

98.97

10.9

7.4

kpa

5.0

5.1

0.64

1446

8295

(3013115) Eosinophils [#/volume] in Blood

4607

35833

1.61

98.79

7.9

6.1

e9/l

0.2

0.67

4076

31310

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2188

14131

1.73

97.60

4.7

3.8

ng/l

212.3

543.1

3.88

1742

11405

(3016502) Oxygen saturation in Arterial blood

1383

7809

1.92

95.98

11.4

7.8

95.4

95.6

0.55

1343

7511

(3028026) IgM [Mass/volume] in Serum or Plasma

839

3997

2.22

92.44

2.0

1.9

g/l

1.3

1.4

0.52

777

3640

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1410

8112

1.88

92.04

1.9

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1411

8131

1.88

91.59

1.9

1.8

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

347

1068

3.34

90.86

1.1

iu/ml

60.4

10258.7

0.54

232

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1276

7136

1.92

90.74

12.1

8.3

g/l

119.0

122.0

5.13

1235

6882

(3037467) Urinalysis macro (dipstick) panel - Urine

5724

47395

1.61

90.40

5.4

4.3

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

110

123

9.04

89.57

3.6

2.8

u/l

3452.9

1090.3

1.06

111

(40768797) Stomach Pathology biopsy report

1574

9455

1.81

89.14

1.4

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

375

1224

3.16

89.13

1.8

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1919

12263

1.72

87.50

3.3

2.8

e6/l

1.1

0.14

1106

7116

(3017143) Hepatitis C virus Ab [Presence] in Serum

1255

7065

1.91

87.21

1.7

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1810

11436

1.74

85.74

3.5

3.1

e6/l

3.1

2.0

3.73

999

6337

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3614

27199

1.56

84.38

2.8

2.2

nmol/l

71.8

77.2

25.25

3270

24330

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3800

28961

1.55

83.63

2.3

2.0

pmol/l

92.3

94.1

1.56

2205

15461

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

836

4210

2.09

79.40

1.6

1.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3667

27964

1.54

79.00

3.6

2.8

ug/l

172.3

150.0

2.63

3363

25736

(3007853) Bacteria identified in Skin by Aerobe culture

1384

8348

1.78

76.13

2.1

1.8

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

794

3993

2.09

75.54

13.5

9.7

mmol/l

23.9

24.2

1.96

747

3702

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1766

11506

1.67

73.16

2.5

2.1

30.5

30.0

1.92

1708

11175

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1337

8153

1.76

70.33

1.7

1.6

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

880

4716

1.96

69.90

13.6

9.3

1.4

1.10

875

4686

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

142

273

5.27

69.82

2.4

1.9

umol/l

89.9

137.8

1.21

138

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

821

4316

2.00

68.88

1.8

1.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2004

13714

1.60

67.37

2.0

1.8

nmol/l

1165.8

1158.0

0.14

1592

10291

(3022217) INR in Platelet poor plasma by Coagulation assay

1560

10094

1.66

65.52

24.9

26.1

inr

1.3

1.4

0.77

260

1431

(3021960) Folate [Moles/volume] in Serum or Plasma

2298

16407

1.54

63.56

1.7

1.6

nmol/l

19.6

19.9

0.33

2022

14065

(3048689) Calprotectin [Mass/mass] in Stool

1220

7515

1.73

61.21

3.4

2.3

ug/g

196.0

140.2

3.96

1031

5928

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

620

3069

2.10

61.12

2.4

1.9

ug/l

2.8

2.3

0.39

551

2702

(3027923) C peptide [Moles/volume] in Serum or Plasma

162

388

4.24

61.05

1.4

1.3

nmol/l

0.9

1.2

3.55

130

301

(3007164) IgA [Mass/volume] in Serum or Plasma

1779

12081

1.59

60.91

1.7

1.5

g/l

2.9

2.5

7.55

1144

7358

(3002256) Pathology report gross observation

1395

8920

1.67

60.88

1.3

—

(3021589) Normoblasts [#/volume] in Blood

3820

30438

1.45

60.71

15.0

9.8

e9/l

0.0

0.47

3201

24837

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1340

8488

1.68

60.59

4.1

4.2

u/l

249.8

243.0

0.48

1252

8008

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2910

22033

1.48

60.02

2.5

2.2

u/l

227.5

232.3

0.11

2731

20646

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

862

4818

1.88

59.89

4.3

3.5

kpa

5.1

0.78

797

4437

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

466

2078

2.31

59.52

1.3

—

(3009343) pH of Capillary blood

850

4749

1.88

59.09

4.3

3.5

7.4

0.08

131

563

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2123

15099

1.54

59.00

2.0

1.8

mg/l

1.6

1.3

2.84

1667

11632

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

760

4109

1.93

58.39

14.7

10.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

548

2639

2.15

57.97

3.1

u/ml

0.3

3.47

297

1514

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

897

5149

1.83

57.11

5.0

3.9

ng/l

110.8

94.2

3.37

774

4418

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1189

7407

1.70

56.94

4.9

3.5

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

821

4592

1.87

56.79

4.2

3.5

mmol/l

1.6

1.8

0.75

596

3363

(3037522) Nuclear Ab [Titer] in Serum

1363

8848

1.64

55.60

1.5

1.3

titre

395.5

498.5

1.45

296

1771

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

651

3405

1.99

55.00

1.8

1.6

g/l

1.6

1.14

565

2894

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

538

2627

2.12

54.85

2.5

2.4

ug/l

431.5

692.6

1.34

511

2487

(3004119) Hemoglobin [Mass/volume] in Venous blood

806

4530

1.86

54.82

4.6

3.4

g/l

128.2

129.4

0.76

779

4422

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

439

1980

2.28

54.53

3.1

2.6

g/l

3.7

3.6

0.81

416

1880

(3035350) Ketones [Presence] in Urine by Test strip

4090

33447

1.42

54.09

4.4

3.6

estimate

0.0

0.23

878

6080

(3013707) Erythrocyte sedimentation rate by Westergren method

5834

50956

1.44

52.51

5.0

4.0

mm/h

15.7

12.4

38.30

5432

47056

(3027945) Reticulocytes/100 erythrocytes in Blood

1295

8437

1.63

51.74

2.9

2.4

1.9

1.8

7.11

1151

7443

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

637

3385

1.95

51.31

4.0

2.8

0.7

0.29

620

3238

(3021601) Nitrite [Presence] in Urine by Test strip

4068

33500

1.40

50.25

5.9

4.9

estimate

0.0

0.80

903

6215

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

158

431

3.72

49.78

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

158

432

3.71

49.61

1.1

1.0

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

136

6.23

49.54

2.1

4.2

u/l

187.4

41.2

1.54

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

331

1384

2.45

48.82

5.8

5.0

iu/ml

895.5

1656.5

0.26

175

(3006922) Hepatitis E virus Ab [Presence] in Serum

162

458

3.59

48.41

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

4095

33896

1.39

48.36

4.5

3.7

estimate

0.0

0.81

844

5988

(3024928) Oxygen saturation in Venous blood

356

1556

2.34

47.54

4.1

3.3

—

(3019060) Gas panel - Arterial blood

850

5069

1.75

47.14

6.5

4.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

449

2167

2.13

47.09

2.3

1.7

—

(3027315) Oxygen [Partial pressure] in Blood

377

1697

2.28

47.00

5.9

4.3

kpa

8.8

8.5

2.16

367

1656

(1616796) Gas panel - Central venous blood

371

1659

2.29

46.98

4.5

3.8

—

(3012501) Base excess in Blood by calculation

375

1688

2.28

46.75

5.8

4.2

mmol/l

2.5

0.11

268

1140

(3013290) Carbon dioxide [Partial pressure] in Blood

375

1689

2.28

46.68

5.8

4.2

kpa

4.9

5.0

1.06

365

1649

(3020191) Ethanol [Moles/volume] in Serum or Plasma

184

578

3.23

46.61

2.1

1.4

promille

1.9

1.3

3.76

135

457

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

406

1898

2.19

46.16

5.1

3.1

mg/l

1.8

1.6

4.73

366

1725

(3036481) Cortisol [Moles/volume] in Serum or Plasma

974

6075

1.68

45.78

2.3

nmol/l

354.8

371.9

1.54

895

5577

(3010421) pH of Blood

413

1959

2.16

45.27

5.6

4.2

7.4

0.16

365

1652

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1048

6686

1.65

45.09

2.6

2.4

ug/l

5.0

7.8

10.17

910

5826

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

432

2095

2.12

44.72

2.6

2.3

84.9

90.3

4.14

408

1962

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1769

12729

1.49

44.59

3.6

3.2

mmol/l

2.5

4.71

1533

11086

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7462

69180

1.55

43.34

30.1

14.9

mg/l

35.6

25.1

88.06

6864

55457

(3023520) Reticulocytes [#/volume] in Blood

991

6326

1.64

42.38

3.0

2.5

e9/l

73.3

69.3

2.52

750

4807

(3020891) Body temperature

552

2984

1.91

42.06

6.6

4.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

363

1686

2.20

41.93

3.6

2.9

kpa

8.2

8.0

0.62

335

1558

(3052851) Hemolysis interference index of Serum or Plasma

432

2149

2.06

41.78

5.0

3.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

392

1881

2.14

41.70

2.7

2.6

218.8

195.3

4.41

374

1789

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2708

21289

1.39

41.65

3.3

3.1

ng/l

1767.1

1556.3

1.26

2371

18291

(3022145) Colonoscopy Study observation

1168

7794

1.58

41.48

1.6

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

240

936

2.61

40.99

1.1

g/l

1.6

1.5

1.37

210

846

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

251

1008

2.53

40.36

8.1

6.5

mg/l

11.9

11.6

0.55

233

931

(3028707) Methadone [Presence] in Urine by Screen method

221

836

2.69

40.13

3.5

2.9

—

(3018405) Lactate [Moles/volume] in Arterial blood

497

2663

1.92

38.86

5.7

4.0

mmol/l

1.5

1.4

0.38

488

2621

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

911

5820

1.63

38.65

5.4

3.9

mmol/l

1.2

6.37

844

5075

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

165

544

3.07

38.58

1.4

1.2

titre

205.4

175.9

0.15

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

165

544

3.07

38.58

1.4

1.2

titre

95.0

113.5

—

(3036489) Thrombin time

481

2559

1.93

38.41

2.4

2.1

22.3

21.5

1.54

437

2253

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

158

510

3.14

38.31

1.3

mmol/l

11.6

0.01

114

144

(3009445) Proteinase 3 Ab [Units/volume] in Serum

558

3122

1.84

38.12

1.5

1.6

u/ml

9.1

17.2

1.02

(3026493) Urate [Moles/volume] in Serum or Plasma

2485

19525

1.38

37.46

3.1

2.7

umol/l

3063.6

4691.3

1.39

2178

16923

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1807

13478

1.43

36.76

1.3

u/ml

1.8

2.0

0.24

469

3551

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

283

1263

2.28

36.01

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

378

1891

2.04

35.97

1.4

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

261

1126

2.36

35.92

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

940

6156

1.59

35.86

2.2

2.5

g/l

65.8

66.3

1.06

862

5582

(3021879) Hepatitis B virus core Ab [Presence] in Serum

742

4586

1.68

35.72

1.5

1.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

387

1960

2.02

35.60

3.6

3.1

mmol/l

24.3

24.8

1.33

341

1703

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

267

1172

2.32

35.32

1.3

1.2

u/ml

301.8

284.0

0.40

171

720

(46235355) HIV 1 and 2 tests - Meaningful Use set

1367

9789

1.47

34.28

1.9

1.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1980

15181

1.39

34.00

1.9

1.7

pmol/l

19530724.8

27780857.4

0.35

1618

12552

(3003181) Sodium [Moles/volume] in Urine

271

1217

2.27

33.99

1.5

1.3

mmol/l

61.2

63.8

0.39

196

975

(3000494) Fungus identified in Specimen by Culture

1170

8135

1.51

33.93

1.7

1.5

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

452

2455

1.89

33.86

1.7

1.6

titre

143.3

313.4

1.47

102

(3028271) Lactate [Moles/volume] in Capillary blood

265

1181

2.28

33.84

2.3

1.9

mmol/l

1.8

1.7

0.71

258

1154

(3048929) Epstein Barr virus Ab [Presence] in Serum

353

1765

2.04

33.64

1.3

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

327

1591

2.10

33.54

3.4

2.5

15.8

16.3

1.39

172

817

(3011397) Hemoglobin [Presence] in Urine by Test strip

2049

15859

1.38

33.09

4.2

3.6

—

(3051651) Icteric interference index of Serum or Plasma

132

421

3.17

32.71

5.6

3.7

—

(3022313) Gas panel - Capillary blood

582

3453

1.73

32.51

4.5

3.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

7609

71681

1.49

32.22

33.0

17.3

mmol/l

138.8

139.7

126.99

7472

69910

(3008152) Bicarbonate [Moles/volume] in Arterial blood

754

4803

1.62

32.12

9.9

7.0

mmol/l

24.3

24.5

0.78

708

4478

(3016650) Hepatitis A virus Ab [Presence] in Serum

247

1094

2.29

32.02

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

8.73

31.87

1.1

—

(3042517) Benzodiazepines panel - Urine

8.73

31.87

4.0

2.3

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

378

1975

1.96

31.81

1.6

1.4

iu/ml

6.2

15.4

—

(3011288) Drugs identified in Urine by Screen method

267

1227

2.21

31.68

3.9

3.2

—

(3029937) Albumin [Presence] in Urine by Test strip

2289

18146

1.35

31.50

5.2

4.0

estimate

0.0

0.25

834

5900

(3027273) Bicarbonate [Moles/volume] in Venous blood

597

3614

1.70

30.97

5.1

3.5

mmol/l

24.7

25.2

2.59

578

3493

(3017181) Myelocytes/100 leukocytes in Blood

894

5983

1.55

30.80

4.0

4.1

1.0

0.25

307

1748

(3023103) Potassium [Moles/volume] in Serum or Plasma

7612

71892

1.47

30.00

33.2

17.5

mmol/l

4.0

5.39

7474

70000

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

311

1562

2.03

29.29

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

311

1562

2.03

29.29

1.5

1.3

—

(3013512) EKG study

2557

20785

1.33

29.26

4.8

4.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

483

2801

1.77

29.19

2.1

1.8

—

(3021901) Oxygen saturation in Capillary blood

288

1409

2.08

29.13

3.5

2.8

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

234

1056

2.25

29.04

3.3

2.6

u/ml

2416.3

1837.6

—

(40768441) Liver Pathology biopsy report

138

487

2.86

28.70

2.0

1.3

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

553

3347

1.70

28.67

5.6

4.1

49.9

48.5

0.62

542

3308

(3026250) Tacrolimus [Mass/volume] in Blood

282

3.50

28.66

40.7

33.5

ug/l

7.0

7.3

0.76

257

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

287

3.48

28.63

3.5

2.6

—

(3025941) Bacteria identified in Stool by Culture

602

3733

1.66

28.46

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

249

1163

2.17

28.41

1.6

1.4

u/ml

123.2

115.4

0.19

242

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

113

363

3.14

27.73

2.9

2.8

—

33.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

269

1309

2.09

27.61

1.7

1.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

768

5097

1.56

27.34

2.0

2.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

511

3070

1.71

27.21

2.2

1.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1899

14925

1.35

26.94

5.4

4.6

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

266

1305

2.07

26.73

1.6

1.4

u/ml

23.1

20.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

151

580

2.63

26.72

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

252

3.56

26.70

1.8

2.2

e6/l

1134.3

3778.2

0.40

174

(3002179) Metamyelocytes/100 leukocytes in Blood

804

5427

1.53

26.47

3.9

0.6

0.7

0.73

228

1265

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

496

2985

1.70

26.24

4.8

3.7

mmol/l

24.5

24.8

1.03

461

2724

(3021440) Promyelocytes/100 leukocytes in Blood

834

5694

1.51

26.02

4.1

0.1

0.2

0.72

279

1620

(40761536) Microorganisms panel - Urine sediment

838

5739

1.51

25.75

5.0

4.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

284

1451

1.99

25.52

3.1

2.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5573

50659

1.28

25.15

4.2

3.8

pmol/l

14.8

0.56

5021

45834

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

192

849

2.29

25.06

3.6

3.4

nmol/l

7.1

13.5

0.46

184

830

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

225

1070

2.13

24.56

1.2

1.3

—

(3033799) Differential panel - Peritoneal fluid

228

3.58

24.55

1.9

1.8

—

(3051611) Lipemic interference index of Serum or Plasma

172

734

2.37

24.38

5.3

3.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

837

5805

1.49

24.12

3.4

2.6

ml/min/173m2

63.8

64.9

0.27

340

2323

(3047181) Lactate [Moles/volume] in Blood

406

2379

1.74

23.65

8.0

6.2

mmol/l

1.6

1.3

3.67

347

2099

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

277

1443

1.95

23.56

1.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

285

1506

1.92

23.24

1.4

—

(3025159) Blasts/100 leukocytes in Blood

774

5335

1.49

22.96

4.2

4.1

0.0

0.3

1.42

232

1369

(4035726)

866

6108

1.46

22.88

1.5

1.4

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

8.55

22.74

1.1

1.0

u/l

39.1

50.4

0.43

(3019225) pH of Specimen

969

6996

1.43

22.59

5.4

4.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

187

860

2.20

22.25

1.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

227

3.41

21.79

1.8

2.0

e6/l

10284.2

17547.3

0.31

123

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

189

881

2.17

21.76

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

187

868

2.18

21.76

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3038

26004

1.26

21.59

4.9

3.8

—

(4198724)

239

3.33

21.47

1.9

2.5

—

(3016879) Cocaine [Presence] in Urine

311

1743

1.81

21.11

3.0

2.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

392

2352

1.70

20.97

2.6

3.3

mg/l

48.9

50.6

0.07

309

1928

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

354

2065

1.74

20.97

1.7

1.6

iu/ml

0.3

7.3

1.25

474

(3025468) Yersinia sp identified in Specimen by Organism specific culture

184

862

2.16

20.93

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

384

2293

1.71

20.91

2.6

3.2

ratio

1.2

3.6

1.79

175

(3005988) Vibrio sp identified in Specimen by Organism specific culture

184

863

2.16

20.87

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

163

728

2.26

20.85

1.2

u/l

59.2

62.2

0.28

120

477

(3034860) Kappa light chains.free [Mass/volume] in Serum

391

2355

1.69

20.62

2.6

3.3

mg/l

77.2

80.3

0.04

309

1931

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

183

861

2.15

20.60

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

311

1757

1.80

20.56

1.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6618

62007

1.28

20.51

5.1

4.5

mu/l

1.9

2.2

2.21

6045

56433

(3000764) Benzodiazepines [Presence] in Urine

326

1870

1.77

20.47

3.0

2.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

273

3.10

20.32

1.7

1.5

iu/ml

2700022.2

1580787.0

—

(3028300) Cannabinoids [Presence] in Urine

326

1885

1.76

19.92

3.0

2.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6820

64238

1.29

19.66

8.0

5.9

mmol/mol

43.7

40.2

89.81

6369

59332

(3027008) Opiates [Presence] in Urine

324

1881

1.75

19.53

2.9

2.1

—

(3044889) 12 lead EKG panel

5398

49541

1.24

19.30

4.5

3.9

—

(40760888) Immunoglobulin light chains.free panel - Serum

308

1770

1.77

19.24

2.7

3.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

374

2273

1.67

19.08

5.9

4.2

mmol/l

3.9

0.57

354

2139

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

298

1702

1.78

19.01

1.6

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

486

3154

1.57

18.99

7.8

5.2

1.8

1.7

0.91

456

2958

(3040151) Glucose [Moles/volume] in Capillary blood

175

837

2.11

18.92

47.1

7.6

mmol/l

8.9

7.4

1.08

146

695

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2184

18204

1.27

18.89

1.8

1.7

mmol/l

1.7

1.4

8.37

1884

15223

(3007930) Methemoglobin/Hemoglobin.total in Blood

479

3109

1.57

18.71

7.8

5.3

0.9

0.36

450

2920

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

173

828

2.11

18.67

1.5

1.6

—

(3044007) Cell count panel - Peritoneal fluid

206

3.32

18.50

2.1

2.0

—

(40768446) Kidney Pathology biopsy report

257

3.05

18.47

1.9

1.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

238

1282

1.88

18.38

1.6

1.7

—

(3027944) Amphetamines [Presence] in Urine

314

1841

1.73

18.30

2.8

2.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6901

65322

1.27

17.67

25.7

14.0

ml/min/173m2

80.7

79.5

3.73

6045

54363

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

235

1283

1.85

17.42

1.3

1.2

—

(3042733) HLA Ab [Presence] in Serum

227

3.10

17.07

5.2

4.9

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

287

1681

1.73

16.81

2.9

2.2

g/l

126.2

129.9

1.39

226

1194

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

311

1864

1.69

16.75

2.2

2.3

ug/min

176.5

103.3

1.37

178

1140

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

331

2024

1.66

16.53

1.5

g/l

1.2

2.35

320

1915

(3019977) pH of Arterial blood

104

424

2.47

16.44

3.9

2.8

7.4

0.06

150

(21494755) Public health laboratory ask at order entry panel

400

6064

0.64

16.30

1.3

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

319

1953

1.66

15.87

1.5

g/l

0.2

1.31

308

1848

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

308

1873

1.67

15.72

1.3

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

404

2628

1.56

15.65

2.4

2.6

—

(40768804) Tissue Pathology biopsy report

3121

27471

1.21

15.55

2.3

2.1

—

(3019150) Specific gravity of Urine by Refractometry

1783

14799

1.26

15.51

5.0

4.1

kg/l

1.0

0.29

252

2217

(3014765) Yersinia sp identified in Stool by Organism specific culture

309

1890

1.66

15.43

1.3

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

316

2.64

15.14

4.4

5.7

mg/l

2455.0

864.2

0.28

217

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

846

6373

1.36

15.10

3.1

2.9

ng/l

240.5

216.2

0.83

780

5794

(42529406) Shigella sp [Presence] in Stool by Culture

309

1901

1.65

15.10

1.3

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

283

1709

1.68

14.86

1.6

1.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

402

2.43

14.85

1.2

u/l

46.5

22.8

1.56

333

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

189

1015

1.88

14.81

1.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

434

2904

1.52

14.80

1.7

2.2

g/l

7.4

0.18

328

2147

(3030981) Hyaline casts [#/volume] in Urine by Automated count

555

3902

1.45

14.79

3.3

2.9

e6/l

0.4

0.3

0.71

546

3817

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

433

2899

1.52

14.72

1.7

2.2

g/l

4.0

3.8

1.76

316

2061

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

433

2903

1.52

14.63

1.7

2.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

408

2703

1.53

14.57

1.7

2.2

g/l

10.9

10.2

1.82

342

2270

(3034274) Bile acid [Moles/volume] in Serum --fasting

103

447

2.32

14.24

2.0

1.9

umol/l

21.4

8.6

2.35

309

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

417

2.37

14.17

1.2

u/l

127.4

88.6

1.99

352

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

406

2708

1.52

14.06

1.8

2.3

g/l

3.2

3.1

1.73

319

2111

(3002385) Erythrocyte distribution width [Ratio]

6015

56544

1.21

13.98

33.3

18.1

14.1

13.7

48.79

5912

55281

(40761535) Cells panel - Urine sediment

787

5941

1.36

13.83

4.1

3.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

154

795

1.95

13.62

2.1

1.7

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.97

13.57

6.2

4.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

220

1272

1.75

13.57

1.4

1.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

211

1206

1.77

13.54

4.2

3.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

114

528

2.17

13.51

1.1

1.0

mg/l

281.0

284.1

0.18

104

476

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

311

1973

1.60

13.45

1.7

2.2

g/l

0.0

0.00

288

1814

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

371

2459

1.53

13.24

2.0

2.3

g/l

0.5

0.9

2.77

321

2100

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

401

2.33

13.09

2.3

1.7

—

(3037121) Protein [Mass/volume] in Urine

368

2443

1.53

13.04

3.4

3.1

g/l

0.4

0.3

1.35

181

1101

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

313

2008

1.58

12.93

1.7

2.2

g/l

0.0

0.76

288

1820

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

140

716

1.97

12.75

2.9

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2100

18056

1.21

12.75

4.3

3.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

266

1653

1.63

12.55

1.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

331

2168

1.55

12.49

1.8

2.2

g/l

0.0

0.08

306

1973

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

340

2242

1.54

12.44

1.7

2.1

g/l

36.5

37.5

2.17

299

1919

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

182

1025

1.79

12.32

1.4

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

101

464

2.19

12.26

1.3

1.4

—

(3037756) Immunofixation for Serum or Plasma

253

1566

1.63

12.14

1.4

1.6

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

164

3.06

12.07

1.6

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

397

2.28

12.05

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

208

1229

1.71

11.92

2.9

3.5

1.1

1.5

2.06

161

933

(3024891) Influenza virus A+B Ag [Presence] in Specimen

277

1763

1.59

11.86

1.2

1.1

—

(3016038) Potassium [Moles/volume] in Urine

458

2.17

11.82

1.4

1.2

mmol/l

30.9

35.9

1.45

392

(3010375) cycloSPORINE [Mass/volume] in Blood

302

2.46

11.80

29.6

25.9

ug/l

121.8

113.2

0.66

250

(3026692) Albumin [Mass/volume] in Peritoneal fluid

177

2.95

11.78

1.4

1.7

g/l

8.7

13.7

3.53

137

(3008757) Leukocyte morphology finding [Identifier] in Blood

148

793

1.88

11.78

4.1

4.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

454

2.17

11.67

1.2

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

210

1255

1.69

11.56

2.4

2.2

u/l

2077.9

4538.0

0.95

471

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

119

598

2.00

11.44

1.4

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

340

2.34

11.23

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

340

2.34

11.23

1.3

1.5

—

(3024471) HLA-A [Type]

221

2.68

11.22

1.0

—

(3024932) HLA-DR beta [Type]

217

2.68

11.06

1.0

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

7.91

11.00

1.2

1.1

mmol/l

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

413

5758

0.70

10.84

1.8

—

(3023419) Bacteria identified in Sputum by Culture

163

927

1.77

10.74

2.2

2.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

347

2377

1.48

10.63

1.6

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

428

2.14

10.48

1.7

1.5

u/l

5.0

5.9

0.27

198

(36660697) Celiac disease serology panel - Serum

635

4841

1.34

10.43

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

131

705

1.87

10.34

1.2

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

413

2950

1.42

10.15

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

164

955

1.73

9.98

1.5

e6/l

7575.9

2165.5

0.48

122

695

(3012441) Differential panel - Pleural fluid

147

833

1.78

9.84

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

250

3737

0.66

9.53

1.4

1.5

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

3.53

9.47

3.9

2.8

pmol/l

166.6

70.8

0.61

(4010399)

639

4945

1.32

9.46

1.4

—

(3003694) ABO and Rh group [Type] in Blood

2105

18527

1.18

9.40

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7592

73734

1.23

9.36

19.3

10.4

u/l

32.5

27.2

23.96

7420

71047

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

114

610

1.88

9.21

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4348

40454

1.15

9.21

2.9

2.7

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

203

2.57

9.18

2.9

3.2

mg/l

9.6

7.8

0.97

169

(3002331) Protein [Mass/volume] in Peritoneal fluid

158

2.79

9.13

1.4

g/l

19.4

25.4

1.40

120

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

117

635

1.85

9.05

2.4

2.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

159

2.78

9.03

2.1

2.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

182

1122

1.64

8.99

1.5

1.4

—

(40761511) CBC panel - Blood by Automated count

7389

71629

1.21

8.92

26.3

14.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

224

2.46

8.91

1.5

2.9

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

148

866

1.72

8.91

1.5

e6/l

38331.5

59906.6

0.67

512

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.60

8.81

1.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

177

1093

1.63

8.70

1.5

g/l

30.8

32.1

0.62

157

983

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

4.12

8.70

2.9

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

221

2.45

8.67

3.1

2.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

221

2.45

8.67

3.1

2.9

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

189

1192

1.60

8.53

1.1

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

193

2.55

8.53

2.4

2.0

mg/l

8.6

9.4

0.55

156

(1761868) Lipid panel - Serum or Plasma

2171

24308

0.86

8.51

3.3

2.9

—

(3036782) Glucose [Moles/volume] in Pleural fluid

129

737

1.76

8.46

1.3

1.4

mmol/l

7.0

6.3

1.39

119

684

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

8.47

8.46

1.0

u/field

1.3

1.4

0.10

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

135

782

1.74

8.44

1.2

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

402

2953

1.38

8.44

1.7

1.9

u/l

38.8

39.0

0.06

355

2583

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

184

1164

1.59

8.22

1.2

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

145

864

1.69

8.20

1.4

1.6

—

(3008295) Osmolality of Serum or Plasma

125

715

1.76

8.18

1.5

1.3

mosm/kgh2o

285.7

279.5

1.28

557

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

161

987

1.64

8.17

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1286

10960

1.20

8.17

1.3

iu/ml

47.4

33.1

1.23

390

3377

(3045788) Cell count panel - Pleural fluid

127

736

1.74

7.96

1.6

1.5

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

3.43

7.92

1.1

2.0

mmol/l

1.1

0.02

(3039000) Anion gap in Blood

251

1721

1.47

7.76

10.9

7.1

mmol/l

11.9

11.3

1.90

224

1549

(3018572) Chloride [Moles/volume] in Blood

251

1722

1.47

7.74

10.9

7.1

mmol/l

104.2

105.1

1.78

224

1550

(3023511) Choriogonadotropin [Units/volume] in Urine

108

604

1.80

7.66

1.6

1.3

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

186

2.48

7.62

2.4

2.6

au/ml

130.4

163.5

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

352

2.05

7.62

1.1

u/l

59.1

30.2

0.69

264

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

373

2.02

7.58

1.9

1.8

u/field

1.9

2.5

0.35

270

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

129

762

1.70

7.57

1.3

u/l

882.3

406.9

0.60

117

727

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

354

2.04

7.51

1.1

u/l

111.8

94.2

0.33

274

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

243

2.27

7.50

2.4

1.6

u/ml

388.9

2255.8

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

278

1970

1.42

7.25

1.7

—

(3012565) Volume of 24 hour Urine

353

2.02

7.20

2.0

2.3

2143.9

1948.6

0.55

307

(3020961) Endomysium IgA Ab [Titer] in Serum

374

2792

1.35

7.14

1.1

titre

40.0

190.7

—

(3045716) Anion gap in Serum or Plasma

348

2.02

7.11

2.8

2.3

mmol/l

9.9

9.2

0.64

274

(40761539) Cells [Type] in Urine sediment by Light microscopy

187

2.41

7.06

1.3

1.2

—

(4281824)

106

605

1.76

7.06

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

469

1.86

6.98

1.4

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

213

2.31

6.96

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

4.37

6.95

1.0

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

102

2.95

6.94

1.3

u/l

1313.5

82.5

0.65

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

415

1.91

6.87

1.4

1.5

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

120

715

1.69

6.86

1.2

1.1

96.1

97.1

0.17

107

664

(3044242) Glucose [Moles/volume] in Arterial blood

388

1.94

6.82

3.5

2.1

—

(3014271) Vancomycin [Susceptibility]

395

1.93

6.82

3.5

3.0

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

150

950

1.59

6.75

1.1

122.8

115.7

1.97

130

850

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

223

2.25

6.71

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

416

1.88

6.50

1.4

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

477

3739

1.29

6.49

3.1

3.2

pmol/l

4.4

0.62

406

3322

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

152

980

1.56

6.36

1.1

—

(44806118)

129

800

1.62

6.36

1.6

1.5

—

(44790048)

129

800

1.62

6.36

1.6

1.5

—

(44790047)

129

800

1.62

6.36

1.6

1.5

—

(44790049)

129

800

1.62

6.36

1.6

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

102

2.85

6.34

8.4

11.5

mmol/l

5.6

5.8

0.20

102

(4306422)

151

975

1.56

6.28

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

105

622

1.70

6.18

1.3

1.5

—

(3010838) Calcium [Moles/time] in 24 hour Urine

319

1.98

6.13

1.2

1.7

mmol/24h

4.1

7.7

—

(3042631) Mycobacterium sp identified in Specimen

160

1054

1.53

6.10

2.4

2.8

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

123

763

1.62

6.07

2.6

3.4

62.0

58.4

1.11

485

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

412

1.85

6.05

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

329

2475

1.34

6.03

1.2

u/ml

0.7

0.8

0.09

232

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

150

977

1.54

6.03

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

151

985

1.54

6.02

2.3

1.9

ug/l

19.9

24.6

0.70

146

966

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

256

1852

1.39

6.00

1.8

1.9

mg/l

11.6

0.03

238

1718

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

275

2.04

5.94

1.5

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

122

760

1.61

5.93

1.1

—

(3008037) Lactate [Moles/volume] in Venous blood

232

1660

1.41

5.81

4.6

3.3

mmol/l

1.7

1.6

0.56

223

1621

(3017569) Oxygen content in Arterial blood

382

1.87

5.80

3.9

2.2

—

(3006270) Folate [Moles/volume] in Blood

105

634

1.66

5.78

1.2

nmol/l

325.0

349.3

0.63

518

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

155

2.39

5.77

2.9

2.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.65

5.73

4.4

1.8

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

168

2.33

5.72

1.1

76.5

86.1

0.73

(3000093) Morphology [Interpretation] in Blood Narrative

113

699

1.62

5.67

1.1

—

(3007463) Buprenorphine [Presence] in Urine

5.89

5.62

8.0

7.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

150

994

1.52

5.60

1.3

1.2

u/ml

4.4

4.3

0.04

427

(40757494) Bilirubin.total [Moles/volume] in Blood

409

1.82

5.57

2.1

2.2

umol/l

31.4

30.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

345

1.89

5.56

3.7

3.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

273

2024

1.36

5.54

1.8

1.7

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

228

1642

1.40

5.52

1.2

1.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

165

2.31

5.49

1.1

1.2

83.3

83.9

0.02

(3010370) Gastrin [Moles/volume] in Serum or Plasma

105

2.67

5.48

2.0

1.8

pmol/l

36.2

42.6

0.23

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

560

1.69

5.47

1.5

1.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

347

1.88

5.47

1.2

1.1

—

(40768443) Skin Pathology biopsy report

394

3087

1.29

5.43

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

117

739

1.59

5.41

3.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

131

851

1.55

5.37

1.2

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

113

711

1.60

5.32

1.7

—

(3004775) Volume in Urine collected for unspecified duration

101

619

1.64

5.29

2.1

2.3

698.9

643.9

0.68

406

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

373

1.83

5.27

2.5

2.1

ug/min

144.5

189.0

0.22

(21494890) Protein electrophoresis panel - 24 hour Urine

122

784

1.56

5.26

1.6

2.0

—

(3004451) EKG impression Narrative

388

1.81

5.25

1.4

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

151

1017

1.49

5.25

1.3

1.2

u/ml

4.0

3.5

0.12

324

(3044927) Protein electrophoresis panel - Urine

118

754

1.57

5.22

1.2

—

(3035880) pH of Pleural fluid

442

1.75

5.14

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1172

10309

1.16

5.01

1.3

1.2

u/ml

9.9

12.5

0.60

420

3966

(3009214) Lutropin [Units/volume] in Serum or Plasma

234

1726

1.37

4.95

1.5

1.4

u/l

9.7

9.1

0.32

180

1400

(3017732) Neutrophils [#/volume] in Blood

575

4764

1.22

4.90

3.3

3.0

e9/l

4.6

4.1

2.86

416

3637

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

127

839

1.52

4.87

1.2

1.3

nmol/l

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

118

769

1.54

4.82

1.7

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

377

1.78

4.82

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

377

1.78

4.82

1.7

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

377

1.78

4.82

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

377

1.78

4.82

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

357

1.80

4.74

1.7

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

357

1.80

4.74

1.7

1.5

—

(40768806) Pleura Pathology biopsy report

128

853

1.51

4.72

1.6

—

(4146454)

119

782

1.53

4.69

2.8

2.7

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

204

2.06

4.67

1.5

—

(3011985) Renin [Units/volume] in Plasma

137

929

1.48

4.65

1.5

1.4

mu/l

66.7

55.6

0.30

124

820

(3021788) Differential panel - Synovial fluid

182

1302

1.41

4.65

1.4

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

174

1236

1.42

4.63

1.2

1.3

u/l

22.7

38.2

2.72

152

1066

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

339

1.80

4.59

1.2

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

193

2.08

4.53

1.1

—

(3016750) Collection duration of Urine

437

1.70

4.52

1.8

2.2

min

493.7

490.5

0.09

318

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

498

1.65

4.51

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

128

867

1.48

4.40

1.4

1.3

pmol/l

273.9

317.3

0.49

649

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

3.00

4.39

1.2

1.3

ml/s/173m2

1.6

1.0

1.30

(3039443) Prostate specific Ag panel - Serum or Plasma

122

1786

0.68

4.38

1.4

1.6

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

118

2.38

4.38

1.2

1.3

mmol/l

1.7

0.01

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

157

2.17

4.32

1.1

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

119

2.36

4.31

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

638

1.56

4.29

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

638

1.56

4.29

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

638

1.56

4.29

1.6

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

6.93

4.16

3.8

2.7

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

6.93

4.16

3.8

2.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

373

1.72

4.13

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

474

3923

1.22

4.13

1.4

1.3

u/ml

244.1

249.4

0.05

440

3622

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

154

2.15

4.10

1.2

1.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

137

955

1.44

4.09

1.2

1.3

nmol/l

0.2

0.55

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

593

1.56

4.01

1.3

u/l

19.3

13.1

0.55

545

(3012920) Ethanol [Mass/volume] in Serum or Plasma

10.01

4.01

2.3

1.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

117

2.31

4.00

1.4

1.3

ng/l

180.5

109.8

0.35

(3049717) Cytology report of Urine Cyto stain

380

3084

1.24

3.99

2.6

2.8

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

540

4548

1.20

3.94

1.7

1.9

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

3.26

3.90

1.0

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

594

5051

1.19

3.90

1.8

1.9

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

291

1.79

3.88

2.7

2.5

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

262

1.84

3.88

1.6

1.9

182.7

155.1

1.22

245

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

158

2.09

3.86

2.3

mmol/l

7.5

8.4

0.41

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

254

1975

1.29

3.82

1.4

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

3.19

3.77

1.0

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

324

2602

1.25

3.76

2.9

3.5

u/ml

64.4

62.3

0.04

311

2506

(3021387) Prolactin [Units/volume] in Serum or Plasma

230

1772

1.31

3.72

1.8

1.7

mu/l

307.6

291.0

0.31

210

1631

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

409

1.64

3.69

1.4

1.5

u/l

5.2

6.7

1.69

349

(3006576) Bicarbonate [Moles/volume] in Blood

289

1.77

3.67

7.4

6.7

mmol/l

24.7

24.8

0.06

265

(4268621)

101

679

1.49

3.67

2.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

402

1.65

3.67

1.3

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

395

1.65

3.64

1.3

1.2

—

(3044941) Cell count panel - Synovial fluid

153

1113

1.38

3.63

1.5

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

290

1.76

3.63

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

290

1.76

3.63

2.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.54

3.62

1.3

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

156

2.06

3.60

1.2

1.1

—

(3035285) Chloride [Moles/volume] in Venous blood

135

964

1.41

3.58

3.2

2.3

mmol/l

105.0

105.6

0.74

135

953

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

292

1.75

3.56

2.0

—

(3038515) Glucose [Moles/volume] in Venous blood

206

1575

1.32

3.54

4.9

3.4

mmol/l

8.6

7.6

2.36

198

1543

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

492

1.57

3.54

3.1

2.4

e6/l

576.9

621.4

0.18

196

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.50

3.53

2.3

2.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

661

1.49

3.52

1.9

g/24h

2.3

0.8

—

(3044290) Cell count panel - Cerebral spinal fluid

181

1360

1.34

3.51

2.0

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

104

711

1.47

3.49

2.0

1.4

—

(3001186) Copper [Moles/volume] in Serum or Plasma

165

2.00

3.48

2.1

1.1

umol/l

15.8

16.4

0.28

147

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

997

8897

1.14

3.47

11.8

7.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

125

2.16

3.47

1.7

ng/l

117.0

138.5

0.36

125

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

332

1.69

3.46

1.5

—

(3017509) Phencyclidine [Presence] in Urine

2.89

3.46

1.8

1.6

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

236

1.83

3.45

1.4

1.3

ug/l

22.7

353.1

1.47

124

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.54

3.45

2.4

2.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

963

8580

1.14

3.43

4.8

4.6

32.1

0.04

728

5846

(3041354) Potassium [Moles/volume] in Venous blood

134

964

1.40

3.42

3.2

2.3

mmol/l

4.1

0.46

134

953

(3020491) Glucose [Moles/volume] in Blood

537

1.53

3.39

1.8

2.0

mmol/l

8.0

6.8

1.88

364

(3000492) Spirometry study

759

6667

1.15

3.34

1.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6865

67210

1.10

3.34

5.5

4.6

mmol/l

6.5

6.0

86.64

6269

61172

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

669

1.47

3.34

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

211

1634

1.30

3.33

1.1

u/ml

6.2

7.6

0.17

193

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2334

24881

0.92

3.30

4.1

4.2

22.3

21.9

0.47

1068

12056

(3017704) Immunofixation for Urine

407

1.60

3.28

1.4

1.5

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

2.78

3.25

3.3

1.5

16.8

18.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

109

2.21

3.24

1.5

1.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.44

3.20

2.9

2.5

u/field

0.4

0.04

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

125

900

1.39

3.20

2.8

2.0

mg/l

19.7

22.8

0.29

224

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

449

1.56

3.20

1.3

titre

524.0

317.3

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

418

1.58

3.18

3.9

2.5

e9/l

0.2

2.23

363

(3007919) Fasciola sp Ab [Titer] in Serum

6.37

3.18

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

130

944

1.38

3.17

3.3

2.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

120

860

1.40

3.16

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

514

1.52

3.16

1.8

2.1

nmol/l

16.3

18.0

1.25

483

(3045414) Leukocytes [Presence] in Urine

370

3076

1.21

3.16

1.9

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1662

17962

0.91

3.15

2.8

3.0

ug/l

0.7

0.8

2.90

1123

11896

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

200

1.85

3.14

1.2

117.8

111.2

0.93

176

(3022621) pH of Urine by Test strip

527

4525

1.18

3.14

3.3

2.9

—

(3000475) Leukocytes [#/volume] in Synovial fluid

223

1756

1.28

3.12

1.7

1.6

e6/l

16583.8

15744.3

0.09

167

1267

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

192

1486

1.30

3.07

2.0

1.3

mmol/l

4.2

3.8

1.22

176

1395

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

439

1.55

3.04

3.8

2.4

e6/l

434.2

481.7

0.50

366

(3033923) Metanephrine [Moles/time] in 24 hour Urine

146

1.99

3.04

1.1

umol/24h

0.6

0.7

0.36

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

269

1.71

3.03

1.2

1.1

miu/ml

1371.8

1532.4

0.53

269

(3009542) Hematocrit [Volume Fraction] of Blood

6405

62598

1.09

3.00

29.6

15.9

38.4

40.0

28.38

4257

44117

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

189

1.86

3.00

1.2

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

211

1.80

2.98

1.7

—

(3000012) Reticulocyte production index

410

1.57

2.97

1.3

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

341

1.62

2.92

2.7

2.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

516

1.50

2.92

1.5

1.6

u/ml

40.3

24.2

0.90

115

(3028679) Herpes simplex virus Ab [Presence] in Serum

303

1.65

2.91

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

108

2.13

2.89

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

139

1038

1.34

2.88

5.3

5.0

umol/l

354.1

360.6

0.19

121

882

(3045424) Erythrocytes [Presence] in Urine

153

1160

1.32

2.87

1.6

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

390

1.57

2.86

3.4

3.9

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

430

1.54

2.86

1.4

1.3

titre

33.3

65.9

—

(3013727) Leukocytes other/100 leukocytes in Blood

244

1.72

2.85

4.2

3.4

60.9

53.7

1.49

233

(3037692) Legionella sp identified in Specimen by Organism specific culture

260

1.70

2.82

1.3

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

186

1.83

2.82

2.2

1.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

364

3060

1.20

2.80

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

165

1.88

2.79

2.9

1.8

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.23

2.77

10.5

4.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.86

2.74

1.1

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

145

1.93

2.74

1.5

1.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

573

1.45

2.74

1.4

1.5

u/l

13.1

12.8

0.13

549

(3001019) Free T4 and TSH panel - Serum or Plasma

233

2874

0.81

2.72

1.6

1.7

—

(3035320) C reactive protein [Mass/volume] in Body fluid

492

1.49

2.72

2.8

2.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

189

1.80

2.69

2.0

1.3

nmol/l

86.5

136.8

2.15

140

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

584

1.44

2.68

2.2

2.0

u/field

2.0

1.6

0.32

238

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6700

65704

1.09

2.67

4.6

4.0

mmol/l

1.5

1.3

24.03

6140

60054

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.13

2.64

1.8

1.4

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

756

0.63

2.61

3.2

2.9

13.4

13.2

0.82

745

(3025315) Body weight

2.55

2.61

4.6

4.8

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

113

2.04

2.60

2.1

1.3

101.7

106.1

0.21

107

(3041918) Cholesterol [Moles/volume] in Pleural fluid

148

1.89

2.59

1.2

mmol/l

1.5

1.6

0.21

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1090

9952

1.11

2.59

1.5

1.4

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

329

1.58

2.58

1.4

1.5

ug/l

8.4

8.3

0.02

286

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

499

1.47

2.55

1.2

—

(40768800) Prostate Pathology biopsy report

150

1932

0.77

2.55

1.2

—

(3011412) CD3 cells [#/volume] in Blood

651

1.40

2.50

3.3

2.3

e9/l

1.0

1.1

1.03

393

(3002619) Bacteria identified in Specimen by Culture

129

1.94

2.49

1.0

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

186

1479

1.26

2.48

2.0

1.4

e6/l

9.7

20.2

1.33

132

1132

(3020393) Adenovirus Ag [Presence] in Stool

2.32

2.48

1.4

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

186

1481

1.26

2.45

2.0

1.4

e6/l

461.4

1297.0

1.90

147

1198

(3036525) Urea [Moles/time] in 24 hour Urine

2.67

2.44

3.4

3.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

319

1.57

2.42

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

464

1.47

2.42

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

2.94

2.41

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

3.34

2.39

6.4

5.7

umol/l

526.7

428.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

6.25

2.37

1.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

208

1691

1.24

2.31

1.9

1.3

mg/l

499.7

533.3

0.36

197

1603

(3050794) Legionella sp Ab [Presence] in Serum

2.37

2.29

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.22

2.27

2.8

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.07

2.26

1.2

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

127

1.89

2.25

1.3

1.5

10.3

8.7

0.17

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

106

1.98

2.25

1.7

2.0

umol/l

14.7

17.8

0.65

106

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

187

1513

1.24

2.18

1.2

1.3

miu/ml

189.4

207.4

0.29

643

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

312

1.54

2.18

1.3

1.4

56.0

64.9

0.87

258

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

2.24

2.17

3.4

1.6

37.8

60.4

—

(40757373) Influenza virus identified in Isolate

151

1.79

2.15

1.5

1.6

—

(3034426) Prothrombin time (PT)

242

1.61

2.15

1.3

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

115

1.92

2.15

1.2

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

119

1538

0.77

2.14

1.3

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

180

1456

1.24

2.12

2.9

3.0

nmol/l

0.8

0.28

134

1095

(3000034) Microalbumin [Mass/volume] in Urine

707

1.35

2.11

3.0

mg/l

148.2

54.1

0.89

523

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

152

1.78

2.11

1.5

ug/l

0.4

0.17

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

388

1.47

2.10

1.1

—

(3023410) Appearance of Cerebral spinal fluid

648

1.36

2.09

3.1

1.5

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

5.00

2.07

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.02

2.05

1.3

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

103

1.94

2.04

1.3

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

488

4318

1.14

2.03

1.2

—

(21494815) CD4 cells/100 lymphocytes in Specimen

592

1.37

2.03

3.0

2.2

37.7

42.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.11

2.02

1.2

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.08

2.01

5.6

7.7

—

(21491868) Cryoglobulin [Mass/volume] in Serum

255

1.57

2.00

1.2

g/l

0.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.28

1.97

1.2

1.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

4.55

1.94

1.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

726

6600

1.11

1.92

2.4

2.2

nmol/l

12.5

13.0

0.90

608

5861

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

677

1.33

1.90

1.3

1.5

28.9

28.2

0.06

417

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

178

1459

1.22

1.89

1.7

iu/l

3.9

4.5

0.36

502

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

459

5167

0.88

1.89

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

498

1.39

1.89

1.5

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

129

1.78

1.85

6.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

429

3793

1.14

1.84

2.5

2.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

114

891

1.28

1.83

1.4

1.6

57.5

60.9

0.40

564

(37021550) Renin [Units/volume] in Plasma --upright

152

1.71

1.82

1.4

1.3

mu/l

114.4

66.0

0.48

115

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

191

1.63

1.80

1.4

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.06

1.80

1.6

1.5

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.57

1.80

2.4

1.6

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

207

1.60

1.79

2.8

2.9

—

(3029075) Extractable nuclear Ab panel - Serum

184

1.63

1.77

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

227

1920

1.19

1.76

5.3

4.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

329

1.46

1.75

1.1

1.3

50.4

61.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

280

1.50

1.75

1.1

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.09

1.75

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.90

1.75

3.7

5.7

ug/min

83.4

45.8

1.07

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.33

1.74

1.2

1.1

—

(1002224) Polysomnography panel

242

2829

0.85

1.72

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

685

0.70

1.71

1.1

u/ml

2.5

4.1

0.89

265

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

218

1.56

1.70

1.2

g/l

0.3

1.70

174

(3020650) Glucose [Presence] in Urine

171

1.64

1.69

1.6

1.5

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.00

1.69

1.1

1.2

ug/l

72.9

120.8

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

227

1.54

1.67

1.7

2.0

ug/l

65.1

62.2

0.10

221

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.16

1.66

1.3

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

119

1.77

1.65

1.5

1.2

76.4

74.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

113

896

1.26

1.65

1.3

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.10

1.65

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

260

1.50

1.65

1.3

1.4

1.9

2.4

0.32

222

(3028433) Virus identified in Specimen by Culture

244

1.52

1.64

1.4

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.98

1.64

1.0

1.2

umol/24h

1.7

0.12

(3000060) B lymphocytes [#/volume] in Blood

150

1.67

1.62

5.5

2.2

e6/l

193.7

754.7

0.60

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

505

1.35

1.61

3.2

2.0

13.0

15.0

0.58

205

(3044009) aPTT.lupus sensitive (LA screen)

2.14

1.60

1.1

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

2.50

1.59

1.1

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

191

1.57

1.56

1.8

1.5

ug/l

9.8

9.1

0.39

191

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.88

1.54

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.27

1.53

1.4

umol/24h

540.5

352.3

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.59

1.51

2.1

1.4

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

307

1.44

1.51

1.8

1.6

nmol/l

2.9

6.0

1.07

256

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

320

0.59

1.49

1.3

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

705

1.28

1.48

1.6

1.4

u/l

22.8

28.3

1.11

572

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

116

1.73

1.48

1.4

1.2

76.3

76.7

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

152

1263

1.21

1.48

1.2

u/ml

47.2

42.8

—

121

(3042111) Morphology [Interpretation] in Bone marrow Narrative

155

1291

1.20

1.47

1.7

1.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

411

1.36

1.45

2.6

2.5

34.9

37.5

0.36

140

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

179

1.57

1.45

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

472

1.34

1.44

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

472

1.34

1.44

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

378

1.38

1.43

1.1

1.2

ratio

1.1

0.51

126

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

473

1.33

1.42

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

127

1042

1.22

1.42

1.3

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

624

0.72

1.41

1.0

u/ml

1.4

0.6

0.25

146

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

205

1758

1.17

1.41

1.2

u/ml

17.2

40.9

—

100

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

483

1.33

1.40

3.4

2.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

214

1.50

1.37

7.1

7.3

—

(3047189) Immunofixation for 24 hour Urine

373

1.37

1.4

1.6

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.94

1.36

1.2

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

455

0.68

1.35

1.3

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

164

0.49

1.35

1.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

469

1.32

1.34

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

469

1.32

1.34

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

207

1.50

1.34

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

175

1.54

1.33

1.2

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

191

1638

1.17

1.33

1.2

1.3

u/ml

11.2

6.9

0.31

258

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

470

1.32

1.33

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

1.91

1.33

2.5

3.8

mg/l

1.3

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

211

1828

1.16

1.30

1.9

pmol/l

195.6

203.1

0.51

196

1732

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

612

0.73

1.28

1.2

1.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

157

1330

1.18

1.28

1.2

u/ml

1.8

4.2

—

101

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

132

0.45

1.28

6.7

5.8

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

133

0.45

1.27

3.3

2.9

—

(21494434) Karyotype in Bone marrow

641

1.27

1.1

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

475

1.31

1.25

1.8

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

187

1612

1.16

1.24

1.2

u/ml

1.8

4.8

0.91

161

(3036603) Volume of Urine

467

1.31

1.24

1.9

1.7

1633.0

1871.8

0.64

117

(1617658) Protocol used for examination of sentinel lymph nodes

399

0.68

1.24

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

147

1.57

1.22

2.1

1.8

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

742

0.77

1.21

1.1

u/ml

4.5

3.5

0.19

281

(3010726) Horse dander IgE Ab [Units/volume] in Serum

865

0.78

1.21

1.1

u/ml

1.5

2.4

0.42

199

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

239

0.59

1.20

1.5

1.8

—

(3000330) Specific gravity of Urine by Test strip

400

3630

1.11

1.20

4.4

3.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.70

1.17

1.3

1.2

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.05

1.15

1.5

1.3

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

158

1.52

1.14

1.2

pmol/l

222.3

287.7

0.69

113

(3023323) Follitropin [Units/volume] in Serum or Plasma

239

2113

1.13

1.14

1.4

iu/l

25.0

29.0

1.21

194

1802

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.69

1.13

1.4

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

194

1693

1.15

1.12

1.4

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

690

1.23

1.11

1.4

1.3

e6/l

264345.8

117420.2

0.65

476

(3019832) Treponema pallidum Ab [Presence] in Serum

437

4003

1.10

1.7

1.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

184

1.47

1.10

1.3

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.82

1.08

9.7

2.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

128

1.56

1.08

1.6

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

195

2220

0.88

1.07

1.5

1.7

mg/l

5.6

3.9

0.94

170

1581

(3019174) dRVVT (LA screen)

1.87

1.07

1.1

1.2

—

(3026726) Creatinine [Moles/volume] in Specimen

1.87

1.07

3.5

2.3

umol/l

704.9

539.7

0.14

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1080

0.82

1.07

1.1

u/ml

1.7

0.02

420

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

301

0.66

1.04

1.2

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

229

1.40

1.03

1.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.06

1.02

1.1

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.06

1.02

2.9

1.6

—

(40768793) Breast Pathology biopsy report

1160

0.83

1.01

1.4

1.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.65

1.00

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

861

0.81

0.98

1.3

1.2

mmol/l

7.9

7.5

0.36

640

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

0.00

0.97

0.0

5.9

—

0.8

—

(44806420)

207

1.40

0.96

2.0

2.4

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

182

1.43

0.95

3.5

6.2

56.3

72.2

1.44

146

(3013762) Body weight Measured

0.00

0.95

0.0

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.72

0.92

2.7

1.6

umol/l

53.3

42.3

0.28

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.72

0.92

1.0

1.3

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.73

0.92

1.0

1.8

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.73

0.92

7.0

10.8

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

616

1.22

0.92

1.7

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

226

1.37

0.92

1.7

1.3

umol/l

3.1

4.0

0.85

209

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

526

1.24

0.91

1.2

u/ml

17.6

45.5

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.14

0.91

1.2

1.0

—

(4034850)

253

2283

1.11

0.90

14.9

10.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.60

0.90

1.0

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

272

2465

1.11

0.90

1.7

1.8

nmol/l

39.7

40.7

0.32

265

2383

(3008536) Aspergillus sp Ab [Presence] in Serum

143

1.47

0.89

2.4

2.1

—

(4094501)

184

2065

0.89

0.86

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

111

1289

0.86

1.5

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.82

0.85

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.67

0.85

1.1

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.74

0.82

1.0

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

410

3807

1.08

0.82

1.2

iu/ml

125.1

134.8

0.22

125

1383

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.70

0.80

4.5

3.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.79

0.0

1.1

—

2.8

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.82

0.79

14.3

8.7

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

190

1.37

0.78

6.6

7.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

173

1.39

0.78

1.4

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

286

1.29

0.78

1.0

1.1

98.7

96.8

0.15

225

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

225

1.33

0.77

1.2

37.4

28.4

—

(3006462) Nitrate [Presence] in Urine

322

1.27

0.77

3.1

3.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

954

0.85

0.77

1.1

u/ml

5.5

4.8

0.13

461

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

467

1.22

0.75

1.4

1.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.52

0.75

1.0

1.1

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.54

0.75

1.1

1.0

ug/l

85.9

78.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.57

0.74

1.2

1.0

—

(4024509)

652

1.18

0.73

1.9

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

819

0.84

0.73

1.4

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.00

0.72

1.0

—

(3014051) Protein [Presence] in Urine by Test strip

174

1563

1.12

0.72

2.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

829

1.16

0.72

1.1

u/ml

4.1

3.1

0.46

368

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.80

0.72

1.0

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

211

1.33

0.71

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

134

1.42

0.71

1.1

u/ml

67.0

1.6

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

345

1.25

0.70

1.3

1.5

5.7

3.6

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

130

1152

1.13

0.69

1.7

1.6

—

(3028717) Thiamine [Mass/volume] in Blood

1.56

0.68

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

110

1.46

0.68

2.5

3.0

ng/l

108.6

149.6

—

(3024263) Appearance of Synovial fluid

401

1.22

0.67

1.7

—

(3051593) INR in Capillary blood by Coagulation assay

365

1.23

0.67

3.7

11.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.63

0.66

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

153

1.37

0.66

1.0

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.49

0.66

1.6

2.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.79

0.66

2.4

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

162

1.36

0.66

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.54

0.65

1.3

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

925

0.86

0.64

1.1

u/ml

1.0

1.3

0.12

377

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

710

0.84

0.64

1.6

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

178

1617

1.10

0.63

1.2

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

655

0.84

0.63

1.5

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

190

1.32

0.62

1.3

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

190

1.32

0.62

1.4

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

674

1.16

0.61

1.6

1.4

nmol/l

0.2

0.3

0.79

519

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

741

7094

1.05

0.61

1.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

280

1.25

0.60

1.3

1.1

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.00

0.60

0.0

1.5

—

41.6

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.54

0.59

1.4

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.54

0.59

1.0

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

808

1.14

0.59

1.3

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

291

1.24

0.57

1.1

—

(3014891) Appearance of Pleural fluid

106

1.42

0.57

1.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

658

0.85

0.57

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

657

0.85

0.56

1.5

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

256

2381

1.08

0.55

1.9

2.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

656

0.85

0.55

1.5

1.4

—

(4211845)

357

1.21

0.55

3.2

3.4

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

186

1.29

0.54

1.4

1.3

39.3

33.2

0.31

122

(3007461) Platelets [#/volume] in Blood

7687

76527

1.04

0.53

40.5

21.8

e9/l

250.5

245.1

8.50

7532

74493

(4212803)

1.49

0.53

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.43

0.52

1.0

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

883

1.12

0.52

1.1

—

(3000285) Sodium [Moles/volume] in Blood

100

1.40

0.51

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

602

1.15

0.51

1.1

1.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

206

1.26

0.50

1.1

—

(3003338) MCHC [Mass/volume]

5784

58298

0.98

0.49

36.0

19.0

g/l

331.8

332.8

12.36

5731

57792

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

234

1.24

0.49

2.5

1.9

—

(4133840)

198

1.26

0.49

1.0

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.43

0.49

1.3

1.1

—

(3008898) HLA-B27 [Presence]

216

2010

1.08

0.48

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

289

1.21

0.48

1.6

2.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.49

0.47

1.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

254

1.22

0.46

2.0

2.8

umol/l

29.6

28.9

0.08

186

(4027681)

374

1.18

0.46

1.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

486

1.15

0.45

1.1

mg/l

253.3

289.6

0.74

421

(3035941) MCH [Entitic mass]

7687

76567

1.03

0.45

40.3

21.7

30.4

0.38

7595

75400

(40768795) Lymph node Pathology biopsy report

684

1.13

0.45

1.1

1.2

—

(40765096) Chromosome analysis panel by Banding

219

1.23

0.45

1.2

1.1

—

(3024731) MCV [Entitic volume]

7687

76570

1.03

0.44

40.4

21.7

91.4

91.2

3.64

7596

75402

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

165

1.27

0.44

1.2

1.1

—

(44806071)

1.40

0.44

1.1

—

(3026361) Erythrocytes [#/volume] in Blood

7687

76577

1.03

0.43

40.5

21.8

e12/l

4.4

4.5

106.60

7494

74309

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

157

1.27

0.43

1.4

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

361

0.83

0.43

1.6

1.5

ug/l

2.1

3.8

1.11

296

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.61

0.43

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

433

1.16

0.43

1.4

1.3

u/ml

1.9

1.1

0.24

203

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7014

69788

1.03

0.42

5.6

5.0

mmol/l

2.5

2.7

58.52

6454

64290

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

546

1.14

0.42

3.3

4.9

u/ml

68.8

61.4

0.10

160

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.56

0.42

1.0

1.1

nmol/l

276.4

256.9

—

(3010813) Leukocytes [#/volume] in Blood

7688

76595

1.03

0.42

40.5

21.8

e9/l

7.6

6.8

23.48

7502

74300

(3047007) Chlamydophila sp Ab [Presence] in Serum

860

1.11

0.41

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

158

1.27

0.41

1.3

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.52

0.41

1.0

1.2

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

667

0.88

0.40

1.3

1.4

pmol/l

67.4

112.3

0.47

215

(44813793)

408

1.15

0.40

1.0

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

7687

76597

1.03

0.39

40.8

21.9

g/l

131.2

136.4

146.87

7590

75437

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.31

0.39

7.5

4.6

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.39

0.0

1.1

—

352.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.35

0.37

1.2

1.1

—

(3022475) Manganese [Moles/volume] in Blood

1.35

0.37

1.4

1.5

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

107

1.31

0.37

1.6

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

107

1.31

0.37

1.6

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

107

1.31

0.37

1.5

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

205

2175

0.94

0.36

1.9

1.8

—

(3016228) CD19 cells/100 cells in Blood

300

1.17

0.36

1.7

2.0

8.4

8.6

0.06

289

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

508

1.12

0.35

1.2

mg/l

34.5

43.1

1.24

421

(3025130) Human papilloma virus identified in Specimen

556

1.12

0.34

2.0

1.7

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

178

0.79

0.34

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

178

0.79

0.34

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

178

0.79

0.34

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

178

0.79

0.34

1.0

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

396

1.14

0.33

1.1

nmol/l

3.9

10.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.30

0.33

1.2

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.67

0.32

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

546

0.90

0.29

1.8

1.7

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

241

1.16

0.29

1.7

2.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

249

0.84

0.29

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

232

1.16

0.28

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.32

0.28

1.7

2.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.27

0.27

1.1

1.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

543

0.90

0.27

1.5

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

200

1906

1.05

0.27

1.7

1.9

—

(46235168) Fasting glucose [Moles/volume] in Blood

1.26

0.26

1.3

1.7

mmol/l

8.4

8.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

224

0.85

0.25

1.2

g/l

40.6

39.6

—

121

(3045683) HLA typing for celiac disease panel - Blood or Tissue

330

1.12

0.25

1.1

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.25

0.24

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.71

0.24

1.0

1.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3085

31112

0.99

0.24

4.5

4.8

ug/l

3.0

3.3

0.16

2729

27977

(3043238) Trisomy 21 risk [Likelihood] in Fetus

558

0.91

0.23

1.6

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

143

1.19

0.23

1.4

1.3

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

1.25

0.22

1.2

1.3

25.6

15.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

172

1.16

0.22

1.4

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

305

0.88

0.22

1.1

1.0

u/ml

0.2

2.6

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.21

0.0

2.2

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

1433.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

283

0.88

0.21

1.1

ng/l

1164.0

407.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

423

4121

1.03

0.21

1.3

au/ml

30.5

53.2

1.39

180

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.16

0.21

1.2

1.1

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.21

0.0

2.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

134

0.82

0.20

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

134

0.82

0.20

1.3

nmol/l

10.5

31.9

3.22

107

(3041806) Other cells [#/volume] in Blood by Manual count

108

1.20

0.20

2.4

1.6

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.22

0.20

1.5

1.0

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.20

0.19

3.0

1.5

nmol/l

3.5

4.0

—

(3045142) Bone marrow Pathology biopsy report

840

1.06

0.19

1.3

—

(3005033) Fetal Nuchal fold Thickness US

540

0.93

0.19

1.5

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

376

1.09

0.18

5.8

6.1

u/ml

1557.0

9029.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

233

1.12

0.17

1.2

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

157

1.15

0.17

1.2

1.1

—

(3025577) Chromium [Mass/volume] in Blood

465

0.92

0.17

2.2

2.0

ug/l

1.9

2.2

0.66

384

(3001729) Color of Synovial fluid

0.74

0.17

1.6

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

360

0.92

0.16

1.1

iu/ml

15.1

10.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

715

7259

0.98

0.15

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

381

1.08

0.14

5.1

6.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

938

1.05

0.14

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

294

1.09

0.14

1.6

2.2

ug/l

25.1

245.6

0.57

273

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

511

0.94

0.14

1.0

ng/l

321.3

318.7

0.03

354

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

367

0.93

0.13

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

480

0.94

0.13

2.1

1.9

ug/l

3.3

3.4

0.05

417

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.82

0.13

1.6

1.9

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

375

1.07

0.12

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

268

1.08

0.12

1.4

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.16

0.11

1.6

—

(3002523) Influenza virus A Ag [Presence] in Specimen

935

1.04

0.11

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

327

1.07

0.11

1.1

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

147

1429

1.03

0.11

1.5

—

(40762814) Titanium [Mass/volume] in Blood

126

0.87

0.11

2.6

2.3

ug/l

3.1

3.9

—

(3035933) Granulocytes/100 leukocytes in Blood

163

1.10

0.10

3.0

1.6

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

125

1.12

0.10

1.4

1.2

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

1.14

0.10

1.2

1.3

28.2

32.7

—

(3001556) Androgen free Index in Serum or Plasma

1.11

0.09

1.4

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.09

0.09

3.8

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

513

0.95

0.09

1.0

ng/l

45.8

42.5

0.26

349

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

126

1.11

0.09

1.8

3.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.07

0.08

1.5

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

146

1.10

0.08

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.78

0.08

2.0

1.5

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.77

0.08

1.0

1.1

u/l

7.6

14.5

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.09

0.08

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.09

0.08

1.0

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

459

4539

1.01

0.08

2.5

2.4

au/ml

25.4

22.4

0.21

228

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.08

0.08

4.6

1.8

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

156

1.09

0.08

1.2

1.3

—

(4015189)

205

1.07

0.07

2.0

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.83

0.07

1.2

2.9

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

510

0.96

0.07

1.0

ng/l

891.7

726.4

1.29

340

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

461

1.04

0.07

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.86

0.07

1.4

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

217

1.06

0.06

1.3

1.5

mmol/l

9.4

8.2

0.53

126

(3051387) C reactive protein [Mass/volume] in Capillary blood

154

1562

0.99

0.05

3.9

3.6

mg/l

27.1

28.4

0.18

104

987

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

252

0.95

0.05

1.9

2.5

nmol/l

181.4

146.5

0.84

217

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6793

67889

1.00

0.03

5.0

4.5

mmol/l

1.3

1.4

71.28

6218

62516

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

158

0.95

0.02

7.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

352

1.02

0.01

1.0

1.1

u/l

1.1

0.03

182

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6840

68411

1.00

0.01

5.1

4.5

mmol/l

4.4

4.6

49.85

6326

63371

(3015183) Erythrocyte sedimentation rate

296

0.98

0.00

1.1

1.2

—

(3048879) Bone marrow aspiration report

214

0.98

0.00

1.3

1.6

—

(40758292) HTLV I+II Ab panel - Serum

110

1.00

0.00

1.3

1.4

—

(3022689) Creatine [Moles/volume] in Urine

219

1.00

0.00

1.4

1.5

—

(40765089) Chromosome analysis panel - Blood by G-banded

128

1.02

0.00

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

251

1.00

0.00

1.2

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.88

0.00

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.00

0.00

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.98

0.00

1.4

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.92

0.00

1.3

1.7

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.86

0.00

11.4

3.7

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.91

0.00

8.4

10.7

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.86

0.00

1.0

1.1

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

25.8

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3007916) DNA double strand Ab [Titer] in Serum

0.90

0.00

2.3

1.2

—

87.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.96

0.00

2.4

1.9

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: PANCREATITIS – Acute pancreatitis (for exclusion)

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Acute pancreatitis (for exclusion)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Acute pancreatitis (for exclusion) (PANCREATITIS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints